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Abstract 
Substance use disorders (SUD) and posttraumatic stress disorder (PTSD) are frequently 
comorbid in those who have experienced psychological trauma, although little research has 
investigated the cause and effect relationships between the two. This thesis examined the co-
occurrence of trauma-related symptoms, PTSD, and SUD using Perceived Causal Relations 
scaling in an online community sample (n = 513) and in persons who were or had recently 
attended treatment for SUDs (n = 12). In both samples, participants perceived trauma-related 
reexperiencing and avoidance as significant causes of substance use partly dependent on the 
gender of the respondent, and men reported that dissociative experiences were more of an effect 
than a cause of their substance use. Study results are considered in respect to the self-medication, 
high-risk and susceptibility hypotheses associating PTSD-SUD comorbidity.  
Keywords: Posttraumatic stress, trauma, substance use, comorbidity, perceived causal relations 
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1.0 Introduction 
Persons who abuse alcohol and psychoactive drugs frequently experience posttraumatic 
stress, depression, anxiety, and dissociative experiences, such that these persons may be 
diagnosed with a comorbid, or co-occurring, disorder. Research is needed to clarify the etiology 
of comorbid substance use disorders (SUDs). It may be that in comorbid SUDs, substance use 
and psychological conditions including posttraumatic stress disorder (PTSD), depression, anxiety 
and dissociative disorders are inter-causal. For example, the most widely accepted explanation is 
that many persons abuse substances in order to cope with intrusive symptoms of PTSD, 
depression, anxiety, and dissociative disorders (i.e., the self-medication hypothesis; Brady, Back, 
& Coffey, 2004; Khantzian, 1985). However, substance use can also produce secondary 
symptoms that mimic PTSD, depression, anxiety, and dissociative experiences in and of itself 
(i.e., as in a diagnosis of a substance-induced disorder). Furthermore, long-term substance use 
and addiction can produce a sense of helplessness and hopelessness in the user, in turn the 
primary cause of a secondary affective disorder (i.e., the susceptibility hypothesis; Chilcoat & 
Breslau, 1998a, 1998b). Moreover, states of intoxication and/or withdrawal may increase the risk 
of psychological trauma exposure and hence posttraumatic stress (i.e., the high-risk hypothesis; 
Brady et al., 2004; Chilcoat & Breslau, 1998a, 1998b). Clearly the etiology linking SUD with 
PTSD, depression, anxiety and dissociative disorders is manifold and complex.  
In this thesis I will investigate associations between substance use and posttraumatic 
stress symptomatology, specifically, the reexperiencing of traumatic memories, experiential and 
behavioural avoidance, and the dissociative experiences of depersonalization and derealization. 
In order to do so, I will apply an introspective psychometric framework titled Perceived Causal 
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Relations (PCR) scaling which assesses participants’ own attributions concerning the casual 
associations potentially connecting their different psychological problems (Frewen, Allen, 
Lanius, & Neufeld, 2012; Frewen, Schmittmann, Bringmann, & Borsboom, 2013; Tzannidakis & 
Frewen, 2015). I will examine the co-occurrence of SUDs with posttraumatic stress, depression, 
anxiety, and dissociative disorders and the theories concerning comorbidity of SUDs with 
posttraumatic stress, depression, anxiety, and dissociative experiences. I will then explain the 
PCR methodology and its prior applications as a means of understanding the cause-and-effect 
associations that may be present between comorbid psychological disorders based on the lived 
experience of persons experiencing these conditions. Finally, I will describe the methods and 
results of an online community sample of convenience (n = 513) as well as a clinical sample of 
individuals who are currently attending or have attended treatment for SUDs (n = 12), in which 
both used the PCR methodology to examine the cause and effect relationships between trauma 
symptomatology and substance use. A general conclusion of data collected is to support theories 
that regard psychological trauma exposure and experiences of posttraumatic stress as causal risk 
factors for SUDs, as well as to support the use of PCR as a psychological assessment 
methodology for investigating the etiological significance of experiences of posttraumatic stress 
for SUDs in clinical practice. 
It is important to point out that, within the substance use literature, varying terms are used 
to refer to different substances and SUDs. For example, the American Psychiatric Association 
(APA)’s previous Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM-
IV-TR; APA, 2000) and current manual (5th ed.; DSM-5; APA, 2013) have different terms for 
substance use and disorders. For the purposes of this thesis, unless otherwise stated, a SUD refers 
to substance use, abuse, or dependence that leads to a clinically significant biopsychosocial 
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disorder. The American Psychiatric Association (APA, 2013) currently officially recognizes ten 
substance classes in the DSM-5: alcohol; caffeine; cannabis; hallucinogens, phencyclidine, and 
other; inhalants; opioids; sedatives, hypnotics, and anxiolytics; stimulants such as amphetamine, 
cocaine, and other; tobacco; and other/unknown. However, research referring to the inclusion of 
all substance use classes is relatively rare in the SUDs literature. Therefore, when referring to 
prevalence of substance use and SUDs, I distinguish between use and SUDs whenever possible. 
However, when prior research statistics fail to discriminate between alcohol and other drugs of 
abuse, reference to substance use, abuse, dependence, and disorders can be taken to reflect the 
use of alcohol, drugs, or both. Where possible, I consider research regarding specific substance 
classes. 
 1.1 Substance Use Disorders (SUDs) 
Substance use and abuse is a rather common occurrence in Canada, the United States, and 
other countries across age, educational status, marital status, and sex. The lifetime prevalence of 
being diagnosed with a substance use disorder in Canada is a striking 21.6% (Pearson, Janz, & 
Ali, 2013). Alcohol is the most commonly used substance across age categories in both Canadian 
adults and youth, as well as globally, partly due to its legal availability in comparison to other 
drugs. The Canadian Addiction Survey (CAS) suggested that of the almost 80% of Canadian 
adults who consume alcohol, 44% reported drinking on a weekly basis, and 10% more than four 
times a week (Adlaf, Begin, & Sawka, 2005). The more recent Canadian Alcohol and Drug Use 
Monitoring Survey (CADUMS) provided comparable estimates for young adults (Health 
Canada, 2012). In addition, 16% of adults indicated binge-drinking, defined as drinking five or 
more drinks in one sitting, with just under 25% of drinking adults exceeding the low-risk 
guidelines of no more that two drinks in one sitting suggested for alcohol consumption (Adlaf et 
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al., 2005). The CADUMS, which also defined binge-drinking as consuming more than a 
recommended maximum of five alcoholic beverages in one sitting, gave a 19-29% population 
prevalence for youth binge-drinking in the year prior to the survey (Health Canada, 2012). Other 
studies have also reported high prevalence of binge-drinking, with approximately two youth in 
five (37%) endorsing binge-drinking (Leatherdale, Hammond, & Ahmed, 2008). Between 44% 
to 62% of Canadian youth from grades seven to nine have reported drinking alcohol in various 
surveys, and by grade 12, lifetime use of alcohol among Canadian youth is as high as 77-91%, 
with up to 80% indicating past year alcohol use (Health Canada, 2012).  
Comparable numbers have been found in other countries that have systematically 
assessed rates of alcohol consumption. For example, the Substance Abuse and Mental Health 
Services Administration (SAMHSA; 2013) reported that 71% of American adults had used 
alcohol within the past year, with almost 88% of Americans having a lifetime use of alcohol. In 
fact, 56% had used alcohol and 24% had binge-drank at least once in the month prior to the 
survey (SAMHSA, 2012). Overall, 14.6 % of Americans will be diagnosed with a substance use 
disorder, with the majority of people having an alcohol use disorder (Kessler et al., 2005). 
American youth also show high levels of underage drinking, with 26% of students in grade six 
having reported trying alcohol at least once in one survey (Cleveland, Feinberg, Bontempo, & 
Greenberg, 2008). By grade 12, the number of American youth who had tried alcohol increased 
to 83%, with nearly a third reporting binge drinking five or more drinks in a single sitting at least 
once (Cleveland et al., 2008).  
Although alcohol is generally the most abused substance within Canada and globally, 
other drugs are also found to be in high use. Lifetime cannabis use among Canadians is also 
startlingly high, approximately 41% to 44.5% in national surveys (Adlaf et al., 2005; Health 
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Canada, 2012). Fourteen percent reported using cannabis in the month prior to the CAS survey 
(Adlaf et al., 2005). Besides cannabis, use of other illicit drugs is reported with surprisingly high 
prevalence. For example, use of hallucinogens has a lifetime prevalence of 11.4%, and about 
10% of the Canadian population has tried cocaine at least once (Adlaf et al., 2005). In fact, 
approximately one out of every six Canadians has tried hallucinogens, cocaine, speed, ecstasy, or 
heroin at some point in their lives (Adlaf et al., 2005).  
Substance use among Canadians is generally high relative to international estimates, but 
somewhat lower than that observed among our neighbours to the south. Specifically, substance 
use rates among Americans may be even higher than those for Canadians, with over 40% having 
used any illicit drug sometime in their lives, 44% over the age of 12 having tried cannabis at 
least once in their lives, and 13% having used cannabis at least once in the previous year 
(SAMHSA, 2014). Reported illicit drug use rates for North America, however, are somewhat 
higher than those for many other countries that have been reliably surveyed. According to the 
United Nations Office on Drugs and Crime (UNODC), the global use of illicit drugs such as 
cannabis, cocaine, and opiates is anywhere from 3.4% to 6.6% of adults aged 15-64 (UNODC, 
2012). Cannabis is the most globally used drug with 2.6-5% of adults using, and this number has 
remained relatively stable for several years (UNODC, 2012). As this number has remained 
stable, the percentage of Canadian and American adults who have reported using cannabis is 
disproportionately higher than global norms. 
  Although substance use is very prevalent in North America and worldwide, not all 
persons who abuse substances experience clinically significant adverse social, occupational, or 
health outcomes. As a reiteration, the lifetime prevalence of a SUD in Canada is 21.6% (Pearson 
et al., 2013), and the corresponding rate is 14.6% in the United States (Kessler et al., 2005), 
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clearly far below the prevalence of substance use. Moreover, the majority of diagnosed SUDs are 
alcohol-related.  
The diagnostic criteria for a SUD include presenting with a variety of behavioural, 
cognitive, and physiological symptoms secondary to substance use such as varying severity of 
lack of control, social isolation, failure to perform obligations, risky and hazardous uses of 
substances, craving, tolerance, and withdrawal (APA, 2013). The defining feature of the 
diagnosis of a SUD is that the individual persists in using the substance regardless of significant 
biopsychosocial consequences. Moreover, all of the substances recognized by the APA can be 
present in a SUD with the exception of caffeine. The DSM-5 also contains a category of 
substance-related disorders labeled substance-induced disorders (APA, 2013). SUDs often 
involve polysubstance use, but the unique adverse outcomes of use of each substance should be 
diagnosed independently (APA, 2013). For example, a patient presenting with severe alcohol, 
cannabis, and amphetamine addiction will be diagnosed with three different substance-induced 
disorders.  
A variety of risk factors for SUDs have been identified, including being male (Adlaf et al, 
2005; King & Chassin, 2007; Young et al., 2002), age (rates highest among youth and young 
adults as compared with older age; Adlaf et al., 2005; Fergusson, Boden, & Horwood, 2008; 
Kilpatrick et al., 2000), ethnicity (rates found to be higher among Native Americans, Caucasians, 
and Hispanics than for Asians or those of African descent; McCabe et al., 2007; Merline, Jager, 
& Schulenberg, 2008), family history of SUDs (Kilpatrick et al., 2000; Von Sydow, Lieb, 
Pfister, Höfler, & Wittchen, 2002), and low social support (i.e., relative absence of family and 
other close relationships; Beyers, Toumbourou, Catalano, Arthur, & Hawkins, 2004; Fergusson 
et al., 2008). Unfortunately, Cleveland and colleagues (2008) found that typically risk factors for 
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SUDs are better predictors of future substance use more so than protective factors are of 
predicting non-use. Of particular interest to the present thesis is the relative risk for SUDs 
associated with having experienced one or more traumatic life events. 
 1.2 Posttraumatic Stress Disorder (PTSD) 
About 76% of Canadians will experience a traumatic life event sometime in their lives 
(Van Ameringen, Mancini, Patterson, & Boyle, 2008). This may include being involved in a 
serious accident, war, sexual assault, molestation, assault with a weapon, rape, or witnessing 
death. Although many Canadians are resilient, approximately 7% of will develop lifetime PTSD, 
and 12-month prevalence is estimated at 2.4% (Van Ameringen et al., 2008). On a global level, 
trauma exposure prevalence rates are generally lower than North American rates (e.g. Canada, 
76%; Van Ameringen et al., 2008; United States, 90%; Kilpatrick, Resnick, Milanak, Miller, 
Keyes, & Friedman, 2013), and are at approximately 67% (Karam et al., 2013; Norris & Sloan, 
2014; Stein et al., 2014).  
Diagnosis of PTSD globally is anywhere from 1.1% to 5.6%, if PTSD is broadly defined, 
and consistent with estimates observed for the United States (Karam et al., 2013; Stein et al., 
2014). PTSD is a psychological disorder defined by the repetitive intrusive reexperiencing of one 
or more traumatic events, whether through distressing memories, nightmares, flashbacks, or 
psychological and physiological reactivity to reminders of the event. In addition to 
reexperiencing the event in one or more of these forms, PTSD is also associated with various 
concurrent affective and behavioural symptoms including avoidance behaviour, cognitive and 
emotional sequelae (e.g., cognitive impairment, emotional numbing), and hyperarousal 
(Friedman, 2013). Several factors tend to influence the likelihood that a traumatic event will 
  
8 
result in PTSD. For example, events that involve serious threats (Ozer, Best, Lipsey, & Weiss, 
2003), injuries (Acierno, Kilpatrick & Resnick, 1999), violence and cruelty (Kessler, Sonnega, 
Bromet, Hughes, & Nelson, 1995), betrayal by a person or place representative of safety 
(Brewin, Andrews, & Valentine, 2000; Freyd, 1998), and repetitive trauma (Brewin et al., 2000) 
tend to be particularly likely to lead to PTSD. Additionally, women are statistically more likely 
to have experienced some sort of sexually-related trauma and meet the diagnostic criteria for 
PTSD (Olff, Langeland, Draijer, & Gersons, 2007; Tolin & Foa, 2006). Moreover, meta-analyses 
gathered on PTSD risk factors show that the degree of exposure is reliably predictive of the 
development of PTSD (Brewin et al., 2000; Ozer et al., 2003; Vogt, King, & King, 2007).  
PTSD is often diagnosed in the presence of comorbid psychological disorders, with 
anywhere from 17-50% of women and 15-60% of men with PTSD meeting the criteria for at 
least one other psychiatric condition, depending on the specific comorbid diagnosis (Creamer, 
Burgess, & MacFarlane, 2001; Kessler et al., 1995). PTSD is especially frequently comorbid 
with affective disorders such as major depressive disorder (MDD), thought to be a result of 
trauma exposure being a shared vulnerability and risk factor for both disorders (O’Donnell, 
Creamer, & Pattinson 2004; Spinhoven, Penninx, van Hemert, de Rooij, & Elzinga, 2014). In 
general, 50% to 60% of patients with PTSD also have comorbid depression (Creamer et al., 
2001; O’Donnell et al., 2004; Kessler et al., 1995). Those who have comorbid PTSD and MDD 
may have a more complex patient profile, as patients who have both disorders endorse more 
severe PTSD symptoms and have a more global level of impairment (Momartin, Silove, 
Manicavasagar, & Steel, 2004; Spinhoven et al., 2014). In addition, anxiety disorders and PTSD 
are also frequently comorbid, which may be due in part to overlapping diagnostic features 
including increased startle response, hypervigilance, and irritability. The estimates for a five-year 
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diagnosis of any anxiety disorder with comorbid PTSD range from 27-59% (Spinhoven et al., 
2014), while more conservative values for lifetime prevalence range from 7-31% depending on 
the specific anxiety disorder diagnosed (Kessler et al., 1995). 
 1.3 Common Features between SUD and PTSD 
Dass-Brailford & Myrick (2010) reviewed commonalities in patients diagnosed with 
PTSD and SUD, as well as intervention programs designed to treat both disorders. High trauma 
exposure rates such as those involving childhood maltreatment and abuse are commonly reported 
in people with both PTSD and SUDs, and people who come to be treated for SUDs often meet 
criteria for PTSD (Dass-Brailford & Myrick, 2010). Persons with comorbid disorders often have 
poorer health and psychological functioning than persons with either disorder alone, and their 
PTSD symptoms including hyperarousal and intrusive reexperiencing can prompt drug and 
alcohol abuse as a form of coping (“self-medication”), unfortunately often leading to further 
health problems and dependence. 
1.3.1 Trauma History 
Traumatic experiences, as well as PTSD, are risk factors for SUDs. Those who abuse 
alcohol or drugs are approximately 1.5 to 1.7 times as likely as non-substance users to 
experience at least one traumatic event (Breslau, Davis, Andreski, & Peterson, 1991; Kessler et 
al., 1995). Experiencing physical or sexual assault and witnessing violence increases the risk of 
diagnosis of alcohol, cannabis, and hard drug abuse and dependence, and the number of 
traumatic events significantly predicts substance use behaviours (Dansky, Saladin, Brady, 
Kilpatrick, & Resnick, 1995; Del Gaizo, Elhai, & Weaver, 2011; Kilpatrick, Acierno, Resnick, 
Saunders, & Best, 1997; Kilpatrick et al., 2000), with experiences of sexual assault associated 
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with an especially high risk for substance abuse in women (Breslau, Davis, & Schultz, 2003; 
Danielson et al., 2009; Olff et al., 2007). Women who met criteria for both PTSD and SUD 
reported higher rates of victimization, such as physical assault and sexual molestation, than those 
who are diagnosed with PTSD and no SUD, adding to the evidence that past trauma history may 
be a risk factor for future SUDs as well as PTSD (Saladin, Brady, Dansky, & Kilpatrick, 1995). 
Similarly, women who meet the diagnostic criteria for both PTSD and SUD are more likely to 
have been a victim of childhood abuse and traumatization (Brown & Wolfe, 1994; Polusny & 
Follete, 1995). 
Many studies have shown that the psychological traumas of childhood are also often 
associated with adult substance use. For example, individuals who experienced childhood 
traumas, such as abuse, are more likely to abuse illegal or illicit substances (Simpson & Miller, 
2002) as well as tobacco (Rodgers et al., 2004). In a treatment-seeking sample, childhood 
traumas, and more specifically physical abuse, were associated with a younger age of onset for 
alcohol use, suggesting that there may be differences in adult versus childhood traumas for 
substance use outcomes (Schäfer et al., 2007). Interestingly, there may be a gender difference 
between the type of trauma experienced and the substances used; childhood sexual trauma in 
women has been linked with cocaine and marijuana use, and physical abuse in men was 
associated with cocaine and heroin use (Khoury, Tang, Bradley, Cubells, & Ressler, 2010). 
Similarly, childhood neglect and other psychological traumas can be linked to lifetime opioid 
dependence (Boscarino et al., 2010).  
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1.3.2 Reexperiencing 
 Literature on reexperiencing as a common feature between PTSD and SUD seems to be 
somewhat small and inconclusive. For example, individuals meeting diagnostic criteria for PTSD 
or for both PTSD and SUD reported no significant differences in levels of reexperiencing 
symptoms (Saladin et al., 1995), but most studies seem to focus on rates of revictimization based 
on PTSD symptoms such as reexperiencing, along with substance use (e.g. Messman-Moore, 
Ward, & Brown, 2009; Ullman, Najdowski, & Fillipas, 2009). 
 However, in some populations, reexperiencing may be related to future substance use in 
conjunction with other predictors. In veterans, scores on alcohol and drug screening 
questionnaires positively correlated with reexperiencing symptoms reported five years prior; 
however, in follow-up hierarchical regressions, reexperiencing scores were not predictive of 
future alcohol or drug use (Shipherd, Stafford, & Tanner, 2005). The opposite was found in a 
sample of women in residential treatment for substance use disorders. In this sample, any 
baseline reexperiencing symptom at intake was predictive of future relapse for both alcohol and 
other drug disorders, and for each additional reported reexperiencing symptom, the likelihood of 
relapse increased by a factor of 2.0 (Brown, 2000). Additionally, it has been shown that 
individuals exhibiting high levels of trauma-related symptoms, such as reexperiencing and 
avoidance, display increases in problem alcohol use post-trauma (Nickerson et al., 2014). 
1.3.3 Avoidance 
 Individuals that display comorbid PTSD and SUD had a higher mean number of reported 
avoidance symptoms, as well as arousal symptoms (Saladin et al., 1995), and in a veteran 
population, avoidance was significantly correlated with future alcohol and drug use (Shipherd et 
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al., 2005). Experiential avoidance, the desire and behavioural effort to avoid unwanted internal 
experiences, thoughts, and emotions, can also be linked to substance abuse (Gratz, Bornovalova, 
Delany-Brumsey, Nick, & Lejuez, 2007; Hayes, Wilson, Gifford, Follette, & Strosahl, 1996). It 
has been suggested that experiential avoidance, which seems to heavily overlap with the PTSD 
diagnostic criteria of C1 (“Avoidance of or efforts to avoid distressing memories, thoughts, or 
feelings about or closely associated with the traumatic event(s)”; APA, 2013) can be both a 
mental experience and a physical action, such that the desire to avoid internal experiences is 
completed through the physical act of substance use (Chapman, Gratz, & Brown, 2006). 
Experiential avoidance has been shown to directly predict the tendency to participate in problem 
behaviours such as alcohol and other drug use (Kingston, Clarke, & Remington, 2010).  
 In a clinical sample attending a residential treatment centre for substance abuse, 
individuals who were moderately to severely abused as children displayed significantly high 
levels of experiential avoidance (Gratz et al., 2007). Similarly, in a veteran population, those 
who abused substances and were experiencing heightened arousal also displayed higher levels of 
experiential avoidance (Forsyth, Parker, & Finlay, 2003). This study, coupled with the findings 
from Gratz et al. (2007) suggests that there may be a relationship between trauma, substance use, 
and experiential avoidance. In fact, Kingston and colleagues (2010) found that experiential 
avoidance mediated the relationship between childhood trauma and problem behaviours such as 
substance use, in that childhood traumas predict problem behaviours due to the traumas 
increasing levels of experiential avoidance.  
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1.3.4 Dissociation  
Finally, trauma-related dissociative symptoms have also been strongly associated with 
particularly hazardous substance consumption (Najavits & Walsh, 2012; Seedat, Stein, & Forde, 
2003). In general, high endorsement of trauma-related dissociative experiences tends to co-occur 
with more severe PTSD symptomatology, and as such, a person may attempt to use substances to 
manage their PTSD symptoms (Carlson, Dalenberg, & McDade-Montez, 2012; Najavits & 
Walsh, 2012). Additionally, it seems as though this can be examined with specific substances; 
for example, dissociative symptoms in an alcohol dependent population were found to effect the 
age of onset for the alcohol dependent diagnosis such that there was an earlier onset of 
dependency (Schäfer et al., 2007). However, the dissociative symptoms were also associated 
with emotional abuse in childhood independent of the alcohol dependence, so there may not be a 
clear causal pathway between dissociation, PTSD, and substance use, at least in a treatment-
seeking population. Although the threefold co-occurrence of dissociation, PTSD, and SUDs is 
not an overly common presentation, this presents as frequent enough that clinicians have been 
advised to assess for dissociation in individuals presenting with a SUD (Seedat et al., 2003).  
 1.4 Comorbidity between SUD and PTSD 
Substance abuse has also been associated with various trauma-related disorders including 
PTSD, whether as an outcome, comorbid disorder, or a risk factor (Breslau et al, 2003; Cacciola, 
Koppenhaver, Alterman, & McKay, 2009; Danielson et al., 2009; Del Gaizo et al., 2011; 
Swendsen et al., 2010). Individuals presenting with both PTSD and SUD tend to have a more 
severe clinical profile than those with a SUD in the absence of PTSD (Mills, Lynskey, Teesson, 
Ross, & Darke, 2005). Anywhere from 12-34% of people with an SUD are expected also to meet 
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criteria for PTSD (Center for Substance Abuse Treatment, 2005). Women are two to three times 
more likely to be diagnosed with PTSD when already diagnosed with and receiving treatment for 
an SUD (Center for Substance Abuse Treatment, 2005). A large epidemiological study 
investigating the relationships of PTSD with other disorders in Canadian adults found that 44.7% 
of men with PTSD and 21.3% of women have comorbid alcohol abuse/dependence (Van 
Ameringen et al., 2008). In contrast, comparable rates for comorbid PTSD and substance abuse 
and dependence were 41.8% of men and 19.3% of women (Van Ameringen et al., 2008). In this 
study, PTSD typically resulted from experiencing a sexual assault or molestation, a loved one 
unexpectedly dying, or witnessing the serious injury or death of another person (Van Ameringen 
et al., 2008).  
In addition to PTSD, SUDs are frequently associated with other trauma-related disorders 
including affective disorders and anxiety disorders. Referring first to affective disorders, 
approximately 20% of people with an SUD will meet criteria for a mood disorder, and 20% of 
those with a mood disorder meet criteria for an SUD (Grant et al., 2004). The diagnosis of 
depression does not necessarily increase use of alcohol or cannabis when compared to 
individuals without depression, but individuals with depression are more likely to report hard 
drug use over those without depression (Chakroun, Johnson, & Swendsen, 2010). In fact, 
researchers identified a relationship between positive mood and subsequent alcohol and cannabis 
use such that on a daily basis, positive moods were associated with increased alcohol and 
cannabis use (Chakroun et al., 2010). However, illicit drug use was associated with depressed 
mood (Chakroun et al., 2010).  This seems to be generally at odds with depression being a risk 
factor for an alcohol or cannabis SUD, but suggests that depression may be a risk factor for illicit 
drug use such as cocaine or ecstasy.  
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Largely similar comorbidity rates have been found between SUDs and anxiety disorders. 
Overall, 17% of people with an SUD meet criteria for an anxiety disorder, and 15% of those 
already diagnosed with an anxiety disorder meet criteria for an SUD (Grant et al., 2004). 
Generalized anxiety is particularly associated with substance use (Grant et al., 2004). The 
substance of choice in those with comorbid generalized anxiety and a SUD is most frequently 
alcohol (93%) over drugs (47%; Alegría et al., 2010).  
1.4.1 Theories of Comorbidity between SUDs and Trauma  
 While it is clear that substance use, PTSD, and related disorders are often linked, it is not 
necessarily clear why or how. The high rates of comorbidity between the trauma-related 
disorders and SUDs evidences that they are related, but the pathways between the two are not 
clear. Depression and anxiety disorders are also highly comorbid, and heavily overlap with 
PTSD and SUD comorbidity as well, further complicating the investigation of the pathways 
between the disorders. However, a review of the literature between PTSD and SUD concludes 
two main pathways (Jacobsen, Southwick, & Kosten, 2001). In the first, trauma exposure and 
likely PTSD precede SUD, whereas in the second pathway, SUD precedes trauma exposure and 
PTSD. These two pathways are detailed in the next three sections. 
1.4.2 The Self-Medication Hypothesis  
 One of the dominant theories explaining the high rates of co-occurrence between these 
disorders is the self-medicating hypothesis. This theory posits that a person who is using 
substances is doing so to decrease experiences related to other comorbid disorders often linked to 
trauma exposure, such as to decrease trauma-related emotions such as fear or shame, and to 
suppress memory of the traumatic events (Brady, et al., 2004; Chilcoat & Breslau, 1998a; 
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Khantzian, 1985; Souza & Spates, 2008). In essence, the individual is attempting to decrease, 
avoid, or escape internal and external reminders of a traumatic event through substance use. As 
such, this theory posits that trauma-related symptoms are the primary cause of comorbid SUD 
and further suggests that because SUD-related withdrawal symptoms can also mimic PTSD 
symptoms of hyperarousal, sleep disturbance, irritability, and concentration problems, a person 
will continue using substances (Jacobsen et al., 2001). Withdrawal symptoms support continued 
drug use, creating a reinforcing self-medication cycle that can lead to dependence on the 
substance. 
 The majority of the research investigating PTSD and SUD comorbidity has tended to, at 
least indirectly, support the self-medication hypothesis. Referring to order of disorder onset, 
PTSD more often precedes the development of SUD, suggesting that trauma exposure and PTSD 
are frequently etiologically significant for SUD (Back, Brady, Sonne, & Verduin, 2006; Chilcoat 
& Breslau, 1998a, 1998b; Compton, Cottler, Phelps, Abdallah, & Sptiznagel, 2000; Stewart & 
Conrod, 2003). Further, Del Gaizo and colleagues (2011) found that a diagnosis of PTSD 
partially mediates the relationship between traumatic exposure and substance abuse, as well as 
the relationship between traumatic exposure and poor health outcomes. Chilcoat and Breslau 
(1998a) also found that the risk of substance use increases when the person already has PTSD, 
and that without PTSD the causal link between exposure to trauma and subsequent substance 
abuse is not present, likely due to an individual’s resiliency following a traumatic event 
decreasing the likelihood of their developing PTSD. As well, women who have been physically 
or sexually assaulted are 2.77 times more likely to abuse alcohol and 1.92 times more likely to 
start or increase drug use compared to women who have not been assaulted (Kilpatrick et al., 
1997) and this increased use is particularly pronounced within the two years following the 
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traumatic assault. Increases in substance craving are also associated with PTSD symptom 
severity (Saladin, Drobes, Coffey, Dansjy, Brady, & Kilpatrick, 2003), which would be 
consistent with both PTSD symptoms motivating substance use and a withdrawal mediated 
effect, both as described for the self-medicating theory. 
 Interestingly, Khantzian (1985, 1997) suggested that the substance of choice used by a 
person may be partially influenced by what kinds of psychological symptoms they are attempting 
to self-medicate. For example, an individual use sedating drugs such as alcohol to quell 
hyperarousal, opiates to pacify emotional pain such as trauma-related shame and guilt, or 
stimulants to combat anhedonia, lethargy, fatigue, and other depressive features. Saladin et al. 
(1995) further investigated this, suggesting that those who have alcohol dependence and PTSD 
may display more arousal symptoms, due to the chemical nature of alcohol, than individuals with 
PTSD and a different drug of dependence.  
1.4.3 The High-risk and Susceptibility Hypotheses 
 Notwithstanding the general support for the self-medication theory, two alternative 
hypotheses have been proposed that tend to support substance use as a causal risk factor for 
PTSD, as opposed to the reverse. First, the high-risk hypothesis posits that substance use can 
precede trauma exposure, and that a person using substances is more likely to be engaged in a 
generally more high risk lifestyle, thereby being at an increased risk for exposure to traumatic 
events leading to PTSD (Brady et al., 2004; Chilcoat & Breslau, 1998a, 1998b; Souza & Spates, 
2008). While Chilcoat and Breslau (1998a, 1998b) failed to find evidence to support the high-
risk hypothesis, they mention that they cannot rule it out. However, Kilpatrick et al. (1997) 
partially did find evidence to support the high-risk hypothesis. Results from Kilpatrick and 
  
18 
colleagues’ study suggest that using drugs and alcohol – but not alcohol exclusively – can 
increase risk of future assault within a span of two years by 1.68 to 1.84 in women. This means 
that women who were using drugs and alcohol at the beginning of the survey were almost twice 
as likely to have been physically or sexually assaulted at some point within the next two years 
than those who were not using. However, they also found that assault could lead to substance 
abuse, which provides evidence for the self-medication hypothesis.   
 A second alternate hypothesis to the self-medication theory is the susceptibility 
hypothesis, which, like the high-risk hypothesis, posits substance use as a causal factor for PTSD 
rather than the reverse. The susceptibility hypothesis suggests that a person who uses substances 
is biologically at an increased risk of developing PTSD after trauma exposure, due to factors 
such as increased anxiety and arousal or neurochemical changes in the brain due to chronic 
substance use, along with ineffective coping skills (Brady et al., 2004; Chilcoat & Breslau, 
1998a, 1998b). Kilpatrick et al (1997) suggest that this increased vulnerability may be most 
apparent in those who have a past history of trauma and substance use, as those who had a past 
history of both were most likely to continue to use in the future. However, this position 
confounds the differences between the high-risk and susceptibility hypotheses, as well as the 
self-medication hypothesis. As both prior trauma (susceptibility and potentially self-medication) 
and substance use (high-risk) increase future drug use, it remains unclear as to which factor is 
truly the causal factor.  
 As such, none of these theories is likely able to universally account for the comorbidity 
between SUD and trauma-related disorders such as PTSD. Rather, an integrative model seems 
more likely based on the principles of equifinality, that is, that different cases of comorbid SUD 
and PTSD may have different causes. For example, PTSD may increase risk for SUD via 
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processes described by self-medication theory in some cases, whilst SUD may increase risk for 
PTSD via processes discussed by the high-risk and susceptibility hypotheses. Together, these 
theories may be more complementary than antagonistic, and together may be more capable of 
capturing the causal comorbidity between PTSD and SUDs in different individuals. 
 1.5 Investigating Causality 
 One source of information about the co-occurrence of SUD, trauma exposure, and 
trauma-related symptoms including PTSD is the lived experience and introspections provided by 
persons with such comorbidities. For example, simply asking persons suffering from both SUDs 
and PTSD whether and how their problems with SUDs and PTSD interrelate can help inform 
case conceptualization at the idiographic level such as whether a particular case better matches 
the self-medication theory, better represents an instance of the high-risk hypothesis and/or the 
susceptibility hypothesis, or fits some other form of hypothesized association or independence 
between SUD and PTSD.  
Indeed it would seem rather common and even natural for clinicians to hypothesize the 
psychological problems that their patients are experiencing as primary versus secondary, that is, 
as the primary cause or the secondary outcome of other psychological problems with which they 
are facing. For example, a psychologist may hypothesize any individual’s trauma exposure and 
associated PTSD as the primary cause or secondary effect of their SUD. Consistent with this, 
Palm, Strong, and MacPherson (2009), examining PTSD symptoms, suggested “there is a 
potential for a causal relationship among particular symptoms such that the development or 
exacerbation of one symptom may potentiate or inhibit others during the acute course of 
symptom development”. Moreover, the network approach to understanding psychopathology 
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developed by Borsboom and colleagues similarly regards comorbidity between disorders to be 
the cause of causal associations that emerge at the level of symptoms, especially symptoms that 
diagnostically overlap between the two comorbid disorders, which they refer to as “bridging 
symptoms” (Borsboom, 2008; Borsboom & Cramer, 2013; Borsboom, Cramer, Schmittmann, 
Epskamp, & Waldorp, 2011; Boschloo et al., 2015; Cramer, Waldrop, van der Maas, & 
Borsboom, 2010; Fried et al., 2015; Fried, Epskamp, Nesse, Tuerlinkx, & Borsboom, 2016; 
Kossakowski et al., 2015; Schmittmann et al., 2011). Importantly, such pathways are frequently 
considered bidirectional rather than only unidirectional, although each of the directional 
pathways can vary in strength and dominance (Kraemer, Stice, Kazdin, Offord, & Kupfer, 2001), 
and the network approach generally does not examine this bidirectionality. As a result, one 
individual’s trauma exposure and PTSD may be a strong cause of their SUD, as per the self-
medication theory, whilst their substance use may be only moderately or weakly a causal factor 
for their experience of PTSD symptomatology, as per the high-risk or susceptibility hypotheses; 
the opposite may be true for another individual. 
 1.6 Perceived Causal Relations (PCR) Scaling 
It has been posited that an idiographic or subjectively individualized approach to 
assessing comorbid psychological disorders and the causal relatedness between presenting 
problems can be useful in helping determine case conceptualization and clinical treatment 
regimens (Frewen et al., 2012; Haynes, Mumma, & Pinson, 2009). Following an individualized, 
idiographic approach to theory development, both face and content validity can be increased, and 
when results are found to replicate across persons they can begin to be applied to theory at the 
nomothetic or generalized application level (Haynes & Lench, 2003; Haynes et al., 2009; Strauss 
& Smith, 2009).  
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While a clinician’s role is frequently to link such hypothesized causal chains between 
their patients’ various comorbid presenting problems in the service of developing a case 
conceptualization and treatment plan, the patient him or herself may also hold his or her own 
hypotheses about the cause and effect relationships that their different psychological problems 
exhibit with one another. For example, Kelly's (1963) personal construct theory conceptualizes 
individuals as scientists-researchers who interpret and apply meaning to events occurring in their 
lives, and attribution theory considers an individual as perceiving causal relationships between a 
variety of concepts and the consequences of such inferences (e.g. Kelley & Michela, 1980).  
As a more recent instantiation of such approaches, Perceived Causal Relations (PCR) 
Scaling is a systematic, introspective methodology developed to assess the directional pathways 
people perceive to causally link their own different psychological problems (Frewen et al., 2012; 
Frewen, Schmittmann, Bringmann, & Borsboom, 2013; Tzannidakis & Frewen, 2015). Within 
the PCR methodology, an individual reports the frequency with which they are experiencing a 
variety of symptoms or problems associated with different psychological disorders, and then 
rates the degree to which they attribute each of the endorsed symptoms/problems as the cause of 
all other endorsed symptoms/problems, creating a matrix of perceived causal relationships 
associating the symptoms/problems with one another. The PCR cause and effect outcomes vary 
on which presenting symptoms are endorsed, and a clinician can utilize these outcomes to aid in 
a case conceptualization regarding which psychological symptoms and problems are those 
perceived by the patient to be most causally associated with one another and with functional 
impairment.  
Relationships between symptoms of PTSD, anxiety, major depressive disorder, and 
trauma-altered states of consciousness (TRASC) have been examined using the PCR 
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methodology in three prior studies (Frewen et al., 2012; Frewen et al., 2013; Tzannidakis & 
Frewen, 2015). Both studies revealed bidirectionality, but differential dominance, in the PCR 
linking PTSD and anxiety with depression. In these studies, individuals attributed their intrusive 
reexperiencing of traumatic memories and their anxiety to be more causal of their experience of 
depressive symptoms than they attributed their symptoms of depression to be causal of their 
posttraumatic reexperiencing and anxiety (Frewen et al., 2012; Frewen et al., 2013; Tzannidakis 
& Frewen, 2015). Frewen et al. (2013) further extended PCR scaling to the investigation of 
moderation and mediation. For example, they found that the frequency with which a person 
reported posttraumatic reexperiencing significantly mediated the relationship between increased 
feelings of shame and depression, whilst this mediation pathway was moderated to the extent 
that participants perceived that such pathways were strong (i.e., via PCR; Frewen et al., 2013). A 
significant limitation of these prior studies, however, is that they have only been conducted in 
undergraduate samples, such that the generalizability of findings to community and clinical 
samples is unknown.  
1.6.1 Application of PCR to SUD and PTSD Comorbidity 
The PCR methodology has not previously been used to examine the co-occurrence of 
trauma-related symptoms with SUD in any detail. In prior studies, a single question on the PCR 
inquired about SUDs and found no difference between the overall cause versus effect 
associations SUDs exhibited with other psychological problems. However, the PCR between 
SUDs and PTSD-related symptoms specifically has never been directly examined. Furthermore, 
as Khantzian (1985) has suggested that different substances might be used by an individual 
depending on which psychosocial problems they are suffering from, it is possible that an 
investigation using multiple items reflecting the current DSM-5 substance use categories would 
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yield a pattern of results that a single, general question about substance use would not be 
sensitive to. In other words, it is possible that trauma-related symptoms including reexperiencing 
and avoidance of traumatic memories, and dissociative experiences, relate differentially with the 
use of different substance classes, such as alcohol, tobacco, cannabis, stimulants, hallucinogens, 
and opiates. 
1.7 Hypotheses 
The overarching goal of this study is to extend results from prior studies conducted with 
the PCR methodology, with the results expected to reflect similar values and comorbidity found 
within the prior research literature. The PCR methodology will be evaluating the co-occurrences 
of SUDs and trauma-related symptoms including the reexperiencing of traumatic memories, 
avoidance of internal and external reminders of traumatic events, dissociation (specifically, 
depersonalization and derealization), anxiety and depression. 
Perceived causal relationships examined in the current study can be found in Figure 1. To 
accomplish this, items represent the symptoms for each psychological construct and/or 
psychiatric disorder as found in the DSM-5. Additional measures for verification of trauma 
exposure, PTSD, and SUD will be administered upon completion of the PCR. Adverse childhood 
experiences and traumatic events occurring over the lifetime will also be measured in addition to 
PTSD, as there is the potential to score high on the Posttraumatic Checklist (PCL-5; Weathers et 
al., 2013) without having PTSD. For example, the negative cognitive alterations portion of the 
PCL-5 heavily overlaps with the cognitive and affective symptoms of depression (APA, 2013). 
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Figure 1: Cause and Effect Associations Examined 
 Causal and Effect Associations 
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Based on the literature, I predicted that persons with high lifetime and childhood trauma 
exposure would endorse more frequent substance use, and that trauma-related symptoms, 
specifically reexperiencing, avoidance, and dissociation, would partially mediate the association 
between high trauma exposure and high substance use. These hypotheses will be examined 
separately in men and women, as the literature predicts sex differences in trauma exposure, 
PTSD, and substance use, with men typically at a higher risk for substance use and most non-
sexual trauma exposures, and women typically at a higher risk for sexual traumas and PTSD.  
Within the PCR, the self-medication, high-risk and susceptibility hypotheses will be 
evaluated. The self-medication hypothesis predicts that participants will report that their trauma-
related symptoms are a greater cause of their substance use than is their substance use a cause of 
their trauma symptoms, whereas the reverse is predicted by the high-risk and susceptibility 
hypotheses. These hypotheses will be evaluated separately for trauma-related reexperiencing, 
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avoidance, and dissociative symptoms, and separately in men and women, and confirmed by the 
PCR results indicating to which direction the mean cause and effect associations are significantly 
stronger. Lastly, Khantzian’s position that specific substances are chosen for their specific 
interaction with current psychological and physical symptoms will be examined, especially with 
regard to the clinical participants in Study 2.  
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2.0 Study 1 Methods 
 2.1 Participants 
Participants were recruited through Amazon’s MTurk webservice to complete an online 
survey. The online MTurk portal allows for a large and diverse workforce. Many psychology 
researchers have begun to turn to online methods of recruitment, such as MTurk, due to its 
associated low recruitment costs and relative ease of access to participant populations of low 
prevalence, including persons with psychological disorders (reviewed by Paolacci and Chandler, 
2014; Shapiro et al., 2013). The purpose of MTurk is to allow for access to a wide variety of 
participants through an online labour market. Within this market, participants are able to 
complete computer tasks like psychological self-report surveys and online interventions in return 
for a small payment. As was the case in the present study, the ability of participants to complete 
studies on an external website through the MTurk portal allows for confidential and anonymous 
data collection. The demographical information collected on MTurk participants seems to 
indicate that these online participants are not significantly different from the general populations 
they are drawn from, with certain exceptions, such as the fact that online participants tend to be 
younger, more educated, and less likely to be employed (Goodman, Cryder, and Cheema, 2013; 
Paolacci & Chandler, 2014; Paolacci, Chandler, & Ipeirotis, 2010). Rates for trauma exposure, 
depression, and anxiety disorders have been tested in a prior MTurk study, and found to be 
largely comparable to general population endorsement rates (Shapiro et al., 2013). Interestingly, 
participants in this study reported that they felt more comfortable in disclosing such clinical and 
personal information through an online medium than they would be in person.  
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In the present study, there were no restrictions or exceptions placed on the ability of a 
person to participate, provided that the participant will have had access to the external research 
website as posted within MTurk, and was at least 18 years of age (an MTurk requirement).  
2.2 Materials 
2.2.1 Life Events Checklist (LEC-5) 
The LEC-5 is a 17-item measure of exposure to 16 discrete traumatic events during a 
person’s lifetime, with one additional item used to query whether “other” kinds of traumatic 
events may have occurred that are not represented by the 16 items given (Appendix 1; Weathers, 
Blake, et al., 2013). A sample item asks about experiencing “sexual assault (rape, attempted rape, 
made to perform any type of sexual act through force or threat or harm)” (Weathers, Blake, et al., 
2013). Although there are no published psychometric studies of the LEC-5, changes between the 
LEC for the DSM-IV and the current DSM-5 version (LEC-5) are minimal and no differences 
between the two surveys are expected (Weathers, Blake, et al., 2013). The LEC for DSM-IV had 
a good retest reliability of .82 at one week, and the kappa statistics for all items but one were 
significantly above .50. The LEC significantly correlated with other trauma measures, such as 
the PTSD Checklist, in both a nonclinical population (r = -.48) and a combat veteran population 
(r = .43; Gray, Litz, Hsu, & Lombardo, 2004). For the present study, participants simply 
indicated which if any of the events described by the LEC-5 occurred anytime during their 
lifetime, with their “yes” or “no” answers scored 1 and 0, respectively. The sum of the total 
number of experienced traumatic events for each participant was calculated, and had an 
associated α = .729. 
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2.2.2 Adverse Childhood Experiences (ACE) 
 The ACE measures whether stressful and traumatic events occurred during the first 18 
years of life such as “did a parent or other adult in the household often or very often push, grab, 
slap, or throw something at you or ever hit you so hard that you had marks or were injured?” 
whereby the participants must answer yes or no based on childhood occurrence (Appendix 2; 
Felitti et al., 1998). A higher ACE score is indicative of more or greater exposure to adverse 
and/or stressful experiences, which increases the risk of negative outcomes such as alcoholism 
(Dube et al., 2006), obesity (Williamson, Thompson, Anda, Dietz, & Felitti, 2002), depression 
(Chapman et al., 2004), and intimate partner violence (Whitfield, Anda, Dube, & Felitti, 2003). 
Participants indicated which of the events described by the ACE occurred during their childhood, 
with their “yes” and “no” answers tallied as scored 1 vs. 0, respectively. Test-retest reliability as 
tested by kappa coefficients were considered good for emotional (.66), physical (.55), and sexual 
(.69) abuse on the ACE in a prior study (Dube, Williamson, Thompson, Felitti, & Anda, 2004). 
The internal reliability in this sample for adverse childhood experiences was α = .786. 
 2.2.3 Posttraumatic Checklist (PCL-5) 
The PCL-5 is comprised of 20 items that measure the criteria for a diagnosis of PTSD in 
the DSM-5 (Appendix 3; Weathers, Litz, et al., 2013). For example, an item may ask if an 
individual has “repeated, disturbing dreams of the stressful experience?” (Weathers, Litz et al., 
2013). Possible scores range from 0 to 80, with a score of 38 or above indicating higher 
symptom severity and a probably PTSD diagnosis (Weathers, Litz, et al., 2013). No 
psychometrics from the developers have yet been made available for the PCL-5, but a 
preliminary study shows differences within the DSM-IV-TR and DSM-5 diagnostic criteria that 
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manifests within the PCL measures based on DSM-IV-TR and DSM-5 (Hoge, Riviere, Wilk, 
Herrell, & Weathers, 2014). The DSM-IV-TR PCL-S and the current PCL-5 have similar rates of 
screening for PTSD in soldiers; however, 30% of soldiers that meet the DSM-IV-TR PTSD 
diagnosis with the PCL-S do not meet the DSM-5 PTSD diagnosis with the PCL-5. A similar 
number of soldiers with DSM-5 PTSD as measured by the PCL-5 did not meet DSM-IV-TR 
diagnostic criteria as measured by the PCL-S (Hoge et al., 2014). Previous versions of the PCL 
have exhibited internal consistency reliabilities between .75 and .80, with inter-item reliabilities 
all over .40 (Wilkins, Lang, & Norman, 2011). Convergent validities of two of the prior versions 
of the PCL were between .63 and.90 with measures such as the Clinician Administered PTSD 
Scale (Wilkins et al., 2011). The total sum of the number of stressful experiences was calculated, 
and an associated α = .964 was found. 
Dissociation & TRASC Items. Ten dissociative items were appended to the PCL-5 
based on prior studies conducted by Frewen and colleagues (Appendix 3; Frewen, Brown, & 
Laniu, 2016; Frewen, P. A., Brown, M. F. D., Steuwe, C., & Lanius, 2015). Two of these items 
are intended as measures of the dissociative subtype of PTSD, that is, depersonalization (“Out of 
body experience: Feeling detached or separated from your body, for example, feeling like you 
are looking down on yourself from above, or like you are an outside observer of your own 
body’’) and derealization (“Feeling like what you are experiencing is not real: A change in the 
way you perceive or experience the world or other people, so that things seem dreamlike, 
strange, or unreal”; Frewen et al., 2015). The other eight items relate to the concept of TRASC 
(e.g. Frewen & Lanius, 2015; Frewen et al., 2016). Only the two depersonalization and 
derealization items, however, were examined in regards to this sample, and the internal reliability 
for the two dissociative items was α = .841. 
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 2.2.4 Simple Screening Instrument for Substance Abuse (SSI-SA) 
The SSI-SA was developed by gathering 16 existing items from established measures of 
substance abuse and combining the items into one comprehensive questionnaire to measure 
alcohol and drug abuse (Appendix 4; Center for Substance Abuse Treatment [CSAT], 2005). For 
example, the item “has drinking or other drug use caused problems between you and your family 
or friends?” comes from the Michigan Alcohol Screening Test and the Drug Abuse Screening 
Test (CSAT, 1994; MAST, Selzer, 1971; DAST, Skinner, 1982). Four or more endorsed SSI-SA 
items indicate a moderate to high risk of substance use problems (CSAT, 1994). 
The SSI-SA has 81.9% overall accuracy in identifying the presence of drug or substance 
dependence (Peters, Greenbaum, Steinberg, Carter, Ortiz, Fry, & Valle, 2000). The measure has 
a low rate of false positives, and has the highest sensitivity in identifying alcohol or substance 
dependence out of all multipurpose measures (Peters, et al., 2000; Boothroyd, Peters, Armstrong, 
Rynearson-Moody, & Caudy, 2013). The SSI-SA also exhibits high internal consistency and 
validity between different ethnic categories and sex and a high convergent validity with other 
measures and with reporting presence of substance abuse (Boothroyd et al., 2013). In this 
sample, the internal reliability of the substance use items were calculated at α = .897. 
 2.2.5 Perceived Causal Relations (PCR) Scaling 
 In the context of PCR scaling, participants were first asked how often PCL-5 items 1 and 
4 (both measuring reexperiencing), 6 and 7 (both measuring avoidance), and the 
depersonalization and derealization items developed by Frewen et al. (2015) occurred in the past 
month on a scale ranging from not at all (scored 0) to daily or almost daily for most of the day 
(scored 7; Appendix 5). On the same scale and timeline, participants were also asked about the 
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how frequently they experienced TRASC, the two symptoms of depression (“feeling down, 
depressed, or hopeless”; and “little interest or pleasure in doing things”) and anxiety (“feeling 
nervous, anxious or on edge”; and “not being able to stop or control worrying”) extracted from 
the Patient Health Questionnaire 4-item version (PHQ-4; Kroenke, Spitzer, Williams, & Löwe, 
2009), and nine classes of substance use as assessed in the Alcohol, Smoking and Substance 
Involvement Screening Test (ASSIST; World Health Organization [WHO] ASSIST Working 
Group, 2002). The SUDs items were derived from item two of the ASSIST, which was one of 
the most consistently reliable items across all drug classes at 0.76 in prior research. Following 
completion of the frequency ratings, participants were administered PCR causal association 
questions in the form of “How much do you think your problems with [some ‘Symptom X’] 
cause your problems with [some ‘Symptom Y’]?”. Only the symptoms endorsed as experienced 
by the participant within the past month were inserted into the causal association questions. It is 
important to note that participants were presented with the causal association question of “How 
much do you think your problems with [some ‘Symptom X’] as a cause of problems with [some 
‘Symptom Y’]” as well as “ How much do you think your problems with [some ‘Symptom Y’] 
as a cause of problems with [some ‘Symptom X’]”. However, only certain symptoms were 
analysed in the causal association questions, specifically those of PTSD-related reexperiencing 
and avoidance, and those referring to SUD (Please see Figure 1 for further explanation). 
 2.3 Procedure 
An institutional ethics committee approved all of the procedures and analyses for the 
study. In order to participate, individuals followed an online link via Amazon’s MTurk that 
advertised the study "a computerized survey method for assessing psychological symptoms 
associated with depression and posttraumatic stress disorder". The link was to a website not 
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associated with MTurk. All data collection was anonymous, confidential, and collected on a 
secure, encrypted server. Participants gave their informed consent through button press prior to 
completing the online self-report questionnaires. Participants first gave their demographic 
information including age, sex, current employment or lack thereof, education level, ethnicity, 
current suffering, and whether they had ever been diagnosed with a mental health problem by a 
physician or psychologist (lifetime mental health, present or absent). Participants were then 
asked to complete the self-report questionnaires. Estimated time to complete the entire battery 
was between 20 minutes and one hour. Participants received a small financial compensation. 
 2.4 Statistical Analyses 
Frequencies and mean scores were calculated for the LEC-5 (lifetime traumatic events), 
ACE (childhood traumatic experiences), PCL-5 (PTSD checklist) and SSI-SA (SUD screen), 
with symptom severity scores and cut-off scores calculated for the PCL-5, ACE, and SSI-SA. 
Sex differences in the SSI-SA measure and the WHO ASSIST item for frequency and number of 
substances used were analysed, and correlated with the number of traumatic experiences an 
individual endorsed on the LEC-5 and the ACE. The prevalence of the dissociative subtype of 
PTSD was also reported.  
A number of multiple mediation models of the relationships between trauma exposure 
and substance use were conducted using Model 4 of the SPSS 20 “Process” macro (Hayes, 
2013), with ratings obtained from males versus females analysed separately. Associations 
between childhood traumatic experiences (ACE) and lifetime trauma exposure (LEC-5), on the 
one hand, and substance use (SSI-SA), on the other, were analysed with PTSD reexperiencing 
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(PCL-5 items), PTSD avoidance (PCL-5 items), and dissociation (depersonalization and 
derealization items), analysed as independent and parallel mediators. 
Mean causal association scores (the average rating of how much one symptom/problem 
causes all other symptoms/problems endorsed) and mean effect association scores (the average 
rating of how much one symptom/problem is caused by all other symptoms/problems endorsed) 
were evaluated following methods introduced by Frewen et al. (2012). However, only certain 
items were examined for PCR, to decrease the potentially overly large data matrix. Specifically, 
if a person endorsed all symptoms presented in the PCR, there would be 23 symptom frequencies 
and 506 (23x22) different causal association scores assessed. In other words, in the question 
“How much do you think your problems with [some ‘Symptom X’] cause your problems with 
[some ‘Symptom Y’]?”, the mean causal association score for each particular “Symptom X” 
would be the average of the causal association scores it obtained across up to 22 other “Symptom 
Y’s”. To reduce this very high number of questions, only certain PCR items were followed up. 
Specifically, the six TRASC items, two mood items, and two anxiety items were only followed 
up as a cause or effect of reexperiencing, avoidance, and substance use categories, but not as a 
cause or effect of each other. In contrast, the two reexperiencing items, two avoidance items, and 
nine substance use categories were always assessed in all possible PCR follow up questions if 
endorsed. By way of example, if a participant endorsed alcohol use, anxiety, dissociation, and 
depression items, the participant will be asked about anxiety causing alcohol use, but not anxiety 
causing dissociation or depression. The total number of items (23) subtract the number of items 
not followed up on (10) creates a matrix of only 416 potential associations, thereby lessening the 
amount of follow-up questions a participant would be asked about if they endorsed all items. The 
formula for determining this value was n(n-1)-k(k-1), in which “n” is the total number of items 
  
34 
(23), and “k” is the number of items not followed up (10): 23(22)-10(9) = 416. In all cases, the 
perceived mean cause and effect associations were tested to ensure that the scores were 
significantly different from zero, suggesting that there are actual perceptions of cause and effect 
relationships being reported. 
 As well, tests of means for the PCR between symptom groups for men, women, and all 
participants (without division by sex) were calculated for specific substance categories. 
Whenever possible, effect sizes of were calculated with G*Power (Faul, Erdfelder, Lang, & 
Buchner, 2007). 
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3.0 Study 1 Results 
3.1 Characteristics of Sample 
 Participants were fairly evenly split between sexes, with 54% female (N = 277) and 46% 
male (N = 234), with a total of 513 participants. Age ranged between 18 and 75 years, with 
women being on average 35.53 years (SD = 11.604) and men being on average approximately 
two years younger, at 33.18 years (SD = 10.537), t(505) = 2.373, p = .018, dz = .150. Twenty-six 
percent of women and 17% of men reported current suffering due to a mental illness, with 26% 
of women and 18% of men having reported suffering in the past. In addition, about 73% of 
participants identified as Caucasian, 10% as Mixed Race, 6% as Other Race, and the rest of the 
11% reported one of the other demographic choices. 76% of the participants were employed, and 
about 70% reported having a least some postsecondary schooling. Table 1 shows these statistics. 
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Table 1: Descriptive Statistics for Study 1 
 Most of the participants reported experiencing at least one stressful or traumatic event, 
with 469 (91.8%) participants endorsing at least one lifetime experience on the LEC-5 and 199 
360 (70.1%) participants endorsing at least one adverse childhood experience on the ACE. The 
endorsement of various events can be seen in Table 2. 
  
Sex n % Education n % 
   Male 234 45.8    Completed High school 45 8.8 
   Female 277 54.2    Some College or University Courses 156 30.4 
      College Diploma 99 19.3 
Age (years)      Undergraduate University Degree 133 25.9 
18 – 40 378 74.3 Graduate or Professional University  
Degree 
74 14.4 
   41 – 60 118 23.1    
   > 60 13 2.6 Employed   
      No, not currently 55 10.7 
Ethnicity      No, currently not able 12 2.3 
   Caucasian 375 73.0    Yes, as a student 46 9.0 
   Native American 8 1.6    Yes, self-employed 61 11.9 
   North East Asian 4 0.7    Yes, part-time or full-time 327 63.7 
   South East Asian 20 3.9    Other 6 1.2 
   Pacific (Polynesian) 1 0.2    
West African,   Bushmen 9 1.8 Marital Status   
   Mixed Race 49 9.6     Single 236 46.0 
   Other Race 47 9.2    Common-Law 25 4.9 
      Married 185 36.1 
Psychiatric Diagnosis      Separated 5 1.0 
No  273 53.2    Widowed 6 1.2 
Yes, in the past 107 20.9    Divorced 44 8.6 
Yes, currently 107 20.9    Other 10 1.9 
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Table 2: Frequencies of Lifetime and Childhood Traumatic Experiences in Study 1 
 Total Female Male χ2(1) p 
LEC-5      
Natural disaster 239 (47.0%) 128 (46.4%) 111 (47.6%)     .081 .776 
Fire or explosion 94 (18.4%) 49 (17.7%) 45 (19.2%)     .201 .654 
Transportation accident 329 (64.4%) 179 (64.6%) 150 (64.1%)     .015 .903 
Serious accident 111 (21.8%) 47 (17.0%) 64 (27.6%)   8.349 .004 
Exposure to toxin 62 (12.2%) 23 (8.3%) 39 (16.7%)   8.431 .004 
Physical Assault 243 (47.6%) 127 (45.8%) 116 (49.6%)     .705 .401 
Assault with weapon 64 (12.5%) 28 (10.1%) 36 (15.5%)   3.291 .07 
Sexual Assault 91 (17.9%) 73 (26.5%) 18 (7.7%) 30.382 .000 
Other unwanted sexual 
experiences 
157 (30.7%) 114 (41.3%) 43 (18.5%) 30.604 .000 
Combat or war 18 (3.5%) 4 (1.4%) 14 (6.0%)   7.744 .005 
Captivity 20 (3.9%) 8 (2.9%) 12 (5.1%)   1.693 .193 
Life-threatening illness 85 (16.6%) 46 (16.6%) 39 (16.7%)     .000 .985 
Severe human suffering 81 (16.9%) 38 (13.9%) 43 (18.5%)   1.973 .160 
Witness sudden violent death 53 (10.4%) 16 (5.8%) 37 (15.9%) 13.873 .000 
Witness sudden accidental death 80 (15.7%) 29 (10.5%) 51 (21.8%) 12.322 .000 
Serious injury or harm 38 (7.4%) 13 (4.7%) 25 (10.7%)   6.613 .010 
Other experiences 299 (58.5%) 159 (57.6%) 140 (60.1%     .320 .572 
Any traumatic event on LEC-5 469 (91.8%) 253 (91.3%) 216 (92.3%)     .159 .690 
 
ACE 
     
Psychological abuse 184 (36.1%) 106 (38.3%) 78 (33.5%)   1.259 .262 
Physical abuse 130 (25.5%) 75 (27.1%) 55 (23.6%)     .803 .370 
Sexual abuse 80 (15.7%) 58 (21.0%) 22 (9.5%) 12.633 .000 
Emotional neglect 168 (32.9%) 105 (37.9%) 63 (27.0%)   6.766 .009 
Physical neglect 61 (12.0%) 33 (12.0%) 28 (12.0%)     .000 .995 
Parental divorce/separation 175 (34.3%) 90 (32.5%) 85 (36.5%)     .894 .344 
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Mother figure physically abused  56 (11.0%) 37 (13.4%) 19 (8.2%)   3.505 .061 
Live with a problem alcohol or 
drug user 
139 (27.3%) 80 (28.9%) 59 (25.3%)     .808 .369 
Household mental health issues 158 (31.0%) 97 (35.0%) 61 (26.3%)   4.490 .034 
Household member in prison 43 (8.4%) 21 (7.6%) 22 (9.4%)     .568 .451 
Any traumatic event on ACE 360 (70.6%) 199 (71.8%) 161 (69.1%)     .458 .498 
 Overall, 91.3% of women and 92.3% of men reported experiencing at least one traumatic 
life event on the LEC-5, which is not a significant sex difference, χ2(1) = .159, p = .690. There 
were no significant differences in the number of events experienced on the LEC-5; women 
experienced an average of 3.903 (SD = 2.673) traumatic events and men experienced an average 
4.201 (SD = 2.929) traumatic events, t(509) = 1.203, p = .230. However, more women reported 
experiencing sexual assault (p < .001) and other unwanted sexual experiences (p < .001) on the 
LEC-5, whereas more men reported witnessing a violent (p < .001) or accidental death (p < 
.001), exposure to toxins (p = .004), experiencing a serious injury or harm (p = .010), and 
combat-related traumas (p = .005). 
 Overall, 71.8% of women and 69.1% of men reported experiencing at least one traumatic 
life event on the ACE, which is not a significant sex difference, χ2(1) = .458, p = .498. However, 
women reported experiencing more different kinds of ACE (M = 2.534, SD = 2.544) than men 
(M = 2.112, SD = 2.218), t(508) = -2.004, p = .046, dz = .125. Referring to responses to the ACE, 
women more often reported being the victim of childhood sexual assault (p < .001), feeling 
unloved or unwanted during their childhood (p = .009), and having a family member with mental 
illness during their childhood (p = .034).  
 Within the sample overall, 107 persons (20.9%) scored above the recommended PCL-5 
cut-off score of 38 for a probable PTSD diagnosis (Weathers, Litz, et al., 2013). There was no 
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significant sex difference in the number of participants scoring above the recommended cut-off 
score for a likely diagnosis of PTSD on the PCL-5; 54 (19.5%) women and 52 (22.3%) men 
scored above the cut-off, χ2(1) = .613, p = .435. Similarly, there was no sex difference in 
symptom severity on the PCL-5, t(508) = 0.137, p = .891. A total of 32.7% (29.6% of women 
and 34.6% of men) endorsed the depersonalization and/or derealization items at a score of 3 
(referring to “Quite a bit”), as has been previously recommended to be suggestive of the presence 
of the dissociative subtype of PTSD (Frewen, Brown, Steuwe, & Lanius, 2015). There was no 
sex difference for D-PTSD, t(508) = 1.358, p = .175. The mean frequency symptom scores for 
the PCL-5 and D-PTSD can be seen in Table 3. 
Table 3: Mean Frequency Symptom Scores on the PCL-5 for PTSD and D-PTSD in Study 1  
 Total Female (M, SD) Male (M, SD) t(508) p 
PTSD Symptoms (PCL-5) 20.71 (18.95) 20.83 (18.82) 20.60 (19.07) 0.137 .891 
Dissociative Subtype (PCL-5)     .90 (1.65)     .80 (1.58)   1.00 (1.72) 1.358 .175 
Note: The standard deviations are noted in the parentheses, and the t-tests analysed sex differences.  
 Almost 25% of the participants met the screening criteria for the SSI-SA, suggesting that 
they require further assessment for likelihood of SUD. More men (n = 66, 28.2%) than women (n 
= 56, 20.2%) met the criteria for further assessment, with χ2(1) =  4.454, p = .035. Significant 
gender differences were also observed for the number of substance-related problems endorsed on 
the SSI-SA, with men endorsing on average 2.480 (SD = 3.491) substance-related problems, and 
women endorsing on average 1.801 (SD = 2.943) substance-related problems, t(509) = 2.379, p = 
.018, dz = .149.  
 Lastly, men (n = 164, 70.1%) were more likely than women (n = 165, 59.6%) to report 
the use of any substance in general, χ2(1) = 6.210, p = .013, with men using on average 1.667 
(SD = 1.972) different substances, and women using on average 1.184 (SD = 1.510) substances, 
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t(509) = 3.133, p = .002, dz = .194. The distribution of substance use in the participants, total and 
by sex, shows that significantly more men than women used tobacco, χ2(1) = 4.721, p = .030; 
alcohol, χ2(1) = 9.239, p = .002; cannabis, χ2(1) =  6.875, p = .009; inhalants, χ2(1) = 7.722, p = 
.030; and any substance in general, χ2(1) = 6.120, p = .013. The substance use distributions can 
be seen below in Table 4. 
Table 4: Substance Use Frequencies in Study 1 
 Total (n, %) Female (n, %) Male (n, %) χ2(1) p 
Tobacco 165 (32.3%) 78 (28.2%) 87 (37.2%) 4.721 .030 
Alcohol 264 (51.7%) 126 (45.5%) 138 (59.0%) 9.239 .002 
Cannabis 97 (19.0%) 41 (14.8%) 56 (23.9%) 6.875 .009 
Cocaine 27 (5.3%) 10 (3.6%) 17 (7.3%) 3.386 .066 
Amphetamine Stimulants 32 (6.3%) 14 (5.1%) 18 (7.7%) 1.504 .220 
Inhalants 15 (2.9%) 4 (1.4%) 11 (4.7%) 4.722 .030 
Sedatives 68 (13.3%) 36 (13.0%) 32 (13.7%) 0.051 .822 
Hallucinogens 25 (4.9%) 9 (3.2%) 16 (6.8%) 3.510 .061 
Opioids 25 (4.9%) 10 (3.6%) 15 (6.4%) 2.137 .144 
Any Substance 329 (64.4%) 165 (59.6%) 164 (70.1%) 6.120 .013 
SUD Screen 122 (23.9%) 56 (20.2%) 66 (28.2%) 4.454 .035 
Note: The χ2 test is the comparison between females and males and the p-values are two-tailed. In the 
total column, the n and percentages represent the number in the full sample, whereas for females and 
males the n and percentages represent the numbers for each sex in the sample endorsing the item. Any 
substance is the sum of all of the substances as determined by the WHO ASSIST, whereas the SUD 
screen was determined by the SSI-SA cut-off score of 4.  
3.2 Correlations between Trauma History, PTSD, Dissociation, and SUD 
Correlations for measures of total number of trauma experiences, PTSD, reexperiencing, 
avoidance, dissociative, and substance use symptoms for men and women can be found in Table 
5. Significant correlations were found between all of the measures. Further correlations showing 
the sex differences between number of different trauma experiences (LEC-5 and ACE), trauma-
related symptomatology (reexperiencing, avoidance, and dissociation), and substance use can be 
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found in Table 6. For both men and women, substance-related activity and use scores are 
significantly positively related to childhood and lifetime trauma exposure and trauma-related 
symptomatology.  
Table 5: Correlations between TE, SUD, PTSD, and Dissociation in Study 1 
 1. 2. 3. 4. 5. 6. 7. 
1. LEC-5 1.000       
2. ACE .471* 1.000      
3. PCL-5 PTSD .339* .313* 1.000     
4. PCL-5 Reexperiencing .297* .259* .862* 1.000    
5. PCL-5 Avoidance .312* .249* .837* .848* 1.000   
6. PCL-5 Dissociation .291* .190 .663* .520* .522* 1.000  
7. SSI-SA .279* .263* .295* .234* .238* .303* 1.000 
Note: The correlations include both sexes together. The following tables provide information on 
correlations between trauma-related symptoms and substance use in both genders. 
*p < .01. 
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Table 6: Correlations between Trauma Experiences and Substance Use by Sex in Study 1 
 
WOMEN 
SSI-
SA 
WHO 
ASSIST 
Tobacco Alcohol Cannabis Cocaine Stimulants Inhalants Sedatives Halluc. Opioids 
LEC-5 .269* .384* .335* .232* .237* .071 .057 .056 .177* .114 .204* 
ACE .238* .253* .121 .066 .136 .170* .109 .069 .122 .116 .128 
Reexp. .189* .202* .130 .167* .280* .078 .025 .079 .127 .149 .110 
Avoid. .214* .213* .160* .204* .249* .131 .051 .062 .112 .088 .12 
Dissoc. .178* .276* .147 .178* .179* .241* .110 .143 .078 .192* .227* 
MEN            
LEC-5 .282* .191* .160 .047 .105 .174* .153 .154 .113 .168 .169* 
ACE .325* .240* .115 .139 .183* .206* .170* .227* .173* .181* .218* 
Reexp. .206* .220* .076 .121 .173* .280* .235* .230* .276* .233* .219* 
Avoid. .215* .260* .156 .094 .206* .263* .217* .243* .283* .248* .233* 
Dissoc. .271* .498* .199* .268* .352* .497* .445* .450* .365* .490* .481* 
Note: The SSI-SA screened for need for further assessment of a substance use disorder. WHO ASSIST reported both use of certain substances and 
total number of substances used. 
*p < .01 
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When comparing the strengths of the correlations between men and women, significant 
sex differences were also found for the correlations between the LEC-5 and WHO ASSIST, z = 
2.119, p = 0.032; LEC-5 and tobacco z = 2.090, p = 0.035; and LEC-5 and alcohol, z = 2.115, p = 
0.033, such that women exhibited higher positive correlations than men in all three instances. 
However, men demonstrated higher positive correlations between dissociation and WHO 
ASSIST, Z = -2.927, p = .004, cannabis, Z = -2.182, p = .027, cocaine, Z = -3.323, p < .001, 
stimulants, Z = -4.084, p < .001, inhalants, Z = -3.781, p < .001, sedatives, Z = -3.382, p < .001, 
hallucinogens, Z = -3.791, p < .001, and opioids, Z = -3.257, p < .001. Men also demonstrated 
higher positive correlations with reexperiencing and cocaine use, Z = -2.340, p = .018, 
reexperiencing and stimulant use, Z = -2.395, p = .016, and avoidance and inhalant use, Z = -
2.069, p = .036. The significance of these associations give reason to examine multiple mediation 
models as a means of understanding the link between trauma exposure and SUD by way of 
trauma-related reexperiencing, avoidance, and dissociation separately in women and men. 
3.3 Simultaneous Multiple Mediation Analyses 
 The simultaneous multiple mediations using regression to predict SSI-SA scores from 
trauma exposures by way of trauma-related symptoms (ratings of reexperiencing, avoidance, and 
dissociation from the PCR) can be seen in for women in Figure 2 (LEC-5 trauma exposure) and 
Figure 3 (ACE trauma exposure) and men in Figure 4 (LEC-5 trauma exposure) and Figure 5 
(ACE trauma exposure). Also included are statistics such as confidence intervals (95%) and beta 
weights. For all instances, the total models were significant, as were tests of direct and indirect 
effects, indicating partial mediation in all models. However, only specific mediators were found 
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to be significant; in all models, reexperiencing and avoidance were not significant partial 
mediators, but dissociative experiences were. 
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Figure 2: Simultaneous Multiple Mediation Model of Lifetime Trauma Exposure (LEC-5) on 
SSI-SA Scores by PTSD Symptoms in Women from Study 1 
 
Figure 3: Simultaneous Multiple Mediation Model of Childhood Trauma Exposure (ACE) on 
SSI-SA Scores by PTSD Symptoms in Women from Study 1 
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Figure 4: Simultaneous Multiple Mediation Model of Lifetime Trauma Exposure (LEC-5) on 
SSI-SA Scores by PTSD Symptoms in Men from Study 1 
 
Figure 5: Simultaneous Multiple Mediation Model of Childhood Trauma Exposure (ACE) on 
SSI-SA Scores by PTSD Symptoms in Men from Study 1 
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3.4 Perceived Causal Relations 
 All mean cause and effect associations were significantly different from zero at p < .001, 
suggesting that the individuals perceived relationships between the cause and effect ratings of 
each symptom or substance class. Across substance class, within women, reexperiencing trauma 
was perceived to be more of a cause (M = 3.082, SD = 2.920) than effect (M = 2.257, SD = 
2.729) of substance use, t(114) = 3.581, p  = .001, dz = .206. The same was found in reference to 
avoidance symptoms; women perceived their avoidance symptoms to be a stronger cause (M = 
2.737, SD = 2.917) than effect (M = 2.156, SD = 2.672) of their substance use, t(120) = 2.737, p 
= .007, dz = .147. However, in reference to dissociative symptoms, no significant difference in 
women’s ratings referring to dissociative experiences as perceived to be a cause (M = 2.007, SD 
= 2.842) versus effect (M = 1.914, SD = 2.632) of substance use was observed, t(69) = .326, p = 
.745.  
 Within men, reexperiencing trauma was also perceived to be a greater cause (M = 2.916, 
SD = 2.663) than effect (M = 2.510, SD = 2.465) of substance use, t(107) = 2.106, p = .038, dz = 
.112. However, no significant difference was observed between men’s PCR ratings referring to 
avoidance symptoms as a cause (M = 3.020, SD = 2.908) versus effect (M = 2.732, SD = 2.599) 
of substance use, t(110) = 1.384, p = .169. Finally, men perceived their substance use to be a 
greater cause (M = 2.469, SD = 2.510) than effect (M = 2.142, SD = 2.642) of their dissociative 
symptoms t(80) = -2.004, p = .048, dz = .096.  
A test of the causal ratings of each substance category within the PCR by sex revealed 
significant differences, and overall men and women differed in their cause and effect 
associations. Tobacco (p < .001), alcohol (p = .002), cannabis (p < .001), and sedatives (p = .002) 
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were perceived to be less a cause than an effect of other endorsed psychological symptoms in 
women (Table 7). Specifically, women rated reexperiencing as a significant cause of tobacco 
use, t(56) = 2.870, p = .006, dz = .175, cannabis use, t(33) = 2.664, p = .012 dz = .388, and 
sedative use, t(29) = 2.717, p = .011, dz = .448, and avoidance as a significant cause of tobacco 
use, t(58) = 2.006, p = .043, dz = .140. 
Men also perceived tobacco (p = .001) and alcohol (p = .040) more so as effects than 
causes of other endorsed psychological symptoms (Table 8). However, men perceived that their 
use of amphetamine-type stimulants were more of a cause than an effect of other psychological 
problems they faced, p = .014. Specifically, men reported that reexperiencing caused their 
alcohol use, t(89) = 2.020, p = .046, dz = .213, cannabis use, t(41) = 2.062, p = .046, dz = .318, 
and sedative use, t(29) = 2.134, p = .041, dz = .385, whereas their amphetamine-type stimulant 
use was reported as a cause of their reexperiencing, t(13) = 2.167, p = .046, dz = .579. Similarly, 
hallucinogen use was perceived to be a cause of avoidance, t(13) = 2.256, p = .042, dz = .603. 
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Table 7: PCR Descriptives and Mean Cause and Effect Associations in Women in Study 1 
 Cause Effect Frequency        
Symptom (M) (SD) (M) (SD) (M) (SD) rFC rFE rCE tCE dfCE pCE dzCE 
Tobacco 1.474 2.224 2.974 2.520 1.54 2.689 .035 .128 .646# 6.539 76 .000 .745 
Alcohol 1.989 2.197 2.494 2.405 1.29 1.767 .338# .388# .698# 3.117 122 .002 .281 
Cannabis 1.790 2.487 3.391 3.315   .54 1.599 3.17 .383* .686# 4.078 37 .000 .661 
Cocaine 3.089 2.933 2.818 3.046   .06   .396  .728* .757* .984# 1.418 7 .199 .496 
Amphetamine 
  stimulants 
3.620 3.157 3.705 3.268   .17   .929  .165 .017 .944#   .272 11 .791 .079 
Inhalants 7.202 2.022 6.956 2.444   .02   .269  .165 .017 .944#   .824 1 .561 .288 
Sedatives 2.395 3.151 3.568 2.853   .41 1.291  .254 .213 .758# 3.292 34 .002 .557 
Hallucinogens 4.007 3.717 3.620 3.607   .05   .364  .589 .649 .993# 2.369 6 .056 .866 
Opioids 3.479 3.245 4.443 2.785   .13   .800 -.078 -.139 .841# 1.654 8 .137 .549 
Note: rFC is the correlation between the frequency of the symptom and it’s respective mean causal 
association rating and rFE is correlation between the frequency of the symptom and it’s respective mean 
effect association rating. rCE is the correlation between the symptom mean causal rating and the symptom 
mean effect rating. All p-values apply to two-tailed tests. 
* p < .05, # p < .01. 
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Table 8: PCR Descriptives and Mean Cause and Effect Associations in Men in Study 1 
 Cause Effect Frequency        
Symptom (M) (SD) (M) (SD) (M) (SD) rFC rFE rCE tCE dfCE pCE dzCE 
Tobacco 2.301 2.425 3.166 2.666 1.72 2.627  .002  .136 .654# 3.555 83 .001 .408 
Alcohol 2.200 2.362 2.513 2.496 1.79 1.895  .345#  .437# .819# 2.071 129 .040 .213 
Cannabis 2.572 2.430 2.620 2.298   .86 1.902 -.006  .141 .798#   .473 53 .638 .033 
Cocaine 3.376 2.768 3.058 3.000   .20   .838  .366 -.013 .906#   .398 15 .696 .250 
Amphetamine 
  stimulants 
3.327 2.727 2.657 2.812   .27 1.109  .367  .218 .963# 2.773 16 .014 .884 
Inhalants 3.921 3.096 3.634 3.150   .16   .802  .299  .102 .979#   .373 9 .718 .362 
Sedatives 3.567 2.707 3.763 2.731   .37 1.094  .078  .208 .710#   .860 30 .397 .095 
Hallucinogens 3.638 3.046 2.939 2.934   .21   .908  .526  .397 .871# 1.203 13 .250 .459 
Opioids 3.556 3.083 3.398 3.103   .21   .922  .600*  .371 .801#   .162 13 .874 .081 
Note: rFC is the correlation between the frequency of the symptom and it’s respective mean causal 
association rating and rFE is correlation between the frequency of the symptom and it’s respective mean 
effect association rating. rCE is the correlation between the symptom mean causal rating and the symptom 
mean effect rating. All p-values apply to two-tailed tests. 
* p < .05, # p < .01. 
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4.0 Study 1 Discussion 
 Previous studies have shown that there are strong links between substance use, 
posttraumatic stress, and psychological trauma experiences, but to our knowledge, none of these 
studies have established these links while incorporating the trauma type (i.e. trauma occurring in 
childhood or over the lifespan), the substance classes used, the gender of the user, and the 
comorbidity hypotheses between PTSD and SUD. In particular, to our knowledge, these 
associations have not been examined in reference to the self-medication, high-risk, and 
susceptibility hypotheses. In the current sample, these associations were analysed using PCR 
scaling and simultaneous multiple mediation models in an online convenience sample. As 
expected, consistent with PTSD literature, childhood traumatic experienced were endorsed more 
frequently by women, and lifetime traumatic experiences were endorsed by a large proportion of 
both men and women. Contrary to the literature, there were no sex differences identified in 
PTSD symptomatology in the present sample. However, as expected, substance use in general, 
substance use-related problems, and the potential for an SUD were reported significantly more 
frequently by men than women, especially in reference to particular substances such as tobacco, 
alcohol, cannabis, and inhalant use.  
 The results from the multiple mediation models mostly supported the self-medication 
hypothesis of comorbid PTSD and SUD, or when substance use is a function or a coping 
mechanism for suppressing trauma-related symptoms (Brady et al., 2004; Chilcoat & Breslau, 
1998a). In particular, the multiple mediation models were supportive particularly with regards to 
dissociative experiences as mediators between trauma exposure and substance use whereas 
reexperiencing and avoidance symptoms did not significantly mediate associations between 
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trauma exposure and substance use. Moreover, this was found in both women and men. These 
results were unexpected, as a diagnosis of PTSD was previously found to partially mediate the 
association between trauma exposure and substance use (Del Gaizo et al., 2011), but dissociative 
experiences were not specifically shown to play a role in mediating these associations.  
 Also unexpected were the differences observed between PCR ratings compared to the 
multiple mediation analyses. Consistent with the self-medication hypothesis, PCR scaling 
showed that trauma-related reexperiencing was perceived to be a greater cause than effect of 
overall substance use in both women and men. Similarly, trauma-related avoidance was 
perceived to be more so a cause of substance use than an effect in women. However, overall 
substance use in men was endorsed as being a greater cause of trauma-related dissociative 
symptoms than vice versa, which is a partial support of the high risk and susceptibility 
hypotheses. 
 While there were overall trends in PCR ratings for both men and women, it is important 
to note that the effect sizes significantly varied by substance class used. For example, 
dissociative symptoms were not perceived to be significantly more so a cause than an effect of 
any one substance class. These relationships were only significant when the frequency of 
substance use was averaged across substance class. Additionally, there was evidence for 
Khantzian’s (1985, 1997) assertion that the chemical properties of the substances and the 
person’s inner psychophysiological state may affect the specific drug sought after. Specifically, 
tobacco, cannabis, and sedatives in women, and alcohol, cannabis, and sedatives in men, were 
perceived as more of an effect than a cause of trauma-related reexperiencing and avoidance. In 
other words, use of these specific substances was perceived to be caused by the trauma-related 
symptoms of reexperiencing and avoidance. This may be due to the fact that these substances 
  
53 
tend to act as depressants or relaxants on relevant body systems, such as the central nervous 
system and the cardiovascular system. In contrast, men rated trauma-related reexperiencing and 
avoidance as higher effects than causes of hallucinogens and amphetamine-type stimulants. In 
this, Khantzian’s (1985, 1997) hypothesis holds consistent, as psychedelics can cause 
hallucinations and other alterations in consciousness akin to traumatic flashback and stimulants 
may be used to increase energy in lethargic individuals. However, once more, usage varied 
significantly with different substances used more often, and this should influence interpretation. 
 Further, it should be noted that overall, there were few differences observed between 
trauma-related symptoms and substance use in reference to cause versus effect associations. 
Notwithstanding the trends that were identified, general conclusions from the present study can 
be drawn such that, especially in the case of avoidance and dissociative experiences, participants 
generally tended to perceive their trauma-related symptoms and substance use to be intercausal 
and bidirectional. Therefore, substance use was perceived to be causal of trauma-related 
symptoms, and trauma-related symptoms were perceived to beget substance use. These findings 
are consistent with both the self-medication hypothesis and the high-risk and susceptibility 
hypotheses. The subject of a future study should then be examining in which specific 
circumstances is a person more likely to perceive their trauma-related symptoms as a cause 
versus effect of their substance use. 
 The present study did present with a number of limitations. First, an online convenience 
sample was used for the participants, and as a result, we do not have a comprehensive 
psychodiagnostic history or characteristics beyond the basic demographical information 
collected with which to describe participants. Second, this study did not collect causal 
associations between trauma-related symptoms and substance use behaviours. Rather, causal 
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associations were examined between trauma-related symptoms and frequency of use of specific 
substances. As such, the study cannot provide information detailing how certain substance-taking 
behaviours, such as risk-taking, may causally relate to trauma symptoms. Furthermore, an 
inventory for personality traits was not administered in this study, to abide by Khantzian’s (1985, 
1997) proposition that personality traits may impact substance of choice. As well, all 
assessments required participants to examine causal relations between trauma-related symptoms 
and specific substance use retrospectively. Given that participants would have been using 
substances in the past in order to make these causal connections, time and additional impairment 
in judgments due to substance intake may increase the participants’ susceptibility to reporting 
biases or errors. Relevant to this, age was weakly correlated with LEC-5 scores (r = .103, p = 
.020; not reported in results) and, while this is not a large correlation, it seems logically 
reasonable to conclude that cumulative trauma exposure would increase with age; a limitation of 
the study in this respect was that there was no question included to determine how recently 
traumatic life events occurred.  
 Taking into consideration the limitations inherent in the current study, we can conclude 
that the mediation modeling and the PCR scaling results together implicate all three comorbidity 
hypotheses partially depending on participant sex, PTSD symptoms type, and substance class of 
abuse. Additional research is warranted with similar methodology in participants who are known 
to be trauma-exposed, substance using, and PTSD symptomatic.  
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5.0 Study 2 Methods 
 The clinical sample data for Study 2 were collected from two treatment centres, Westover 
Treatment Centre in Thamesville, Ontario, Canada and Quintin Warner House in London, 
Ontario, Canada. The sample is comprised of 12 participants, some of who were currently in 
treatment for substance use at the time of the interviews, and some of who had commenced from 
a substance use treatment program prior to the interviews. Participants from both treatment 
centres completed the PCR survey and identical additional questionnaires as the participants 
from Study 1, but with some modifications to the PCR method in order to shorten its length as 
these surveys were given in person instead of online (please see Appendix F for the 
questionnaire). Both during and after the questionnaires, the participants were able to elaborate 
on their answers, especially those centered around the nature of the cause and effect associations 
between symptoms of PTSD and specific substances each participant endorsed using during their 
active addiction. Similar to Study 1, participants rated the strength of the cause and effect 
associations between their symptoms, and were then prompted to elaborate on these relationships 
through such questions as “Symptom X was often seen as a cause of Y, can you tell me more 
about that?”. The interviews were to provide descriptive and qualitative data used to enhance 
discernment of findings from Study 1, such that personal experiences with substance use and 
PTSD symptoms were rated to enhance the self-medication, high-risk, and vulnerability 
hypotheses findings from Study 1.  
 The section that follows contains descriptions of each of the 12 participants in the clinical 
sample. In each, details from the phenomenological interviews are included. Additionally, Table 
9 summarizes participant endorsement of both lifetime and childhood traumatic experienced, 
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trauma-related symptoms, and substance use. In order to protect the identity of each participant, 
pseudonyms have been used.  
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Table 9: Descriptive Statistics for Study 2 
 Alan Don Craig Dylan Daniel Sarah Derek Barry Eric Matt Jordan Kyle Sample 
Total 
Mean 
(SD) 
Age 51 55 54 26 60 30 27 44 60 51 29 65 - 46.0 
(14.33) 
Natural disaster N N N N Y N N Y N Y N N 3 (25%) - 
Fire or explosion N N Y N Y N N N N N N N 2 (17%) - 
Transportation 
accident 
Y Y Y Y Y Y Y N Y Y Y N 10 (83%)  - 
Serious accident Y N Y N N Y N N Y Y N N 5 (42%) - 
Exposure to toxin Y N N N N Y Y Y N Y N N 5 (42%) - 
Physical assault Y N Y Y Y Y Y Y N Y Y N 9 (75%) - 
Assault with a 
weapon 
Y N Y Y N N N Y Y Y N N 6 (50%) - 
Sexual assault N N N N N Y N N Y Y Y N 4 (33%) - 
Other unwanted 
sexual experiences 
N N N N N Y N Y Y Y Y N 5 (42%) - 
Combat or war N N N N N N N N N N N N  - 
Captivity N N N N N Y N Y Y N Y N 4 (33%) - 
Life-threatening 
illness 
N Y N Y N Y N Y N Y N N 5 (42%) - 
Severe human 
suffering 
N Y N N N Y N Y N Y N N 4 (33%) - 
Witness sudden 
violent death 
Y N N N Y N N N N N Y N 3 (25%) - 
Witness sudden 
accidental death 
N Y Y N Y N N N N Y N N 4 (33%) - 
Serious injury to 
other 
N N N Y N Y Y Y N Y N N 5 (42%) - 
Other experience N N N Y Y Y N Y Y Y Y Y 8 (67%) - 
LEC-5 Total 6 4 6 6 7 10 4 10 7 13 7 1 - 6.75 
(3.166) 
               
Psychological abuse Y Y Y Y Y Y N Y N Y N N 8 (67%) - 
Physical abuse Y Y Y N Y N N Y N N N N 5 (42%) - 
Sexual abuse N N N N N N N Y N Y Y N 3 (25%) - 
Emotional neglect N Y Y Y Y Y Y Y N Y N N 8 (67%) - 
Physical neglect N N Y N N Y N Y N N Y N 4 (33%) - 
Parental 
divorce/separation 
N N Y N N N Y Y Y N Y N 5 (42%) - 
Mother figure 
physically abused 
N N Y N N N N Y N N N N 2 (17%) - 
  
58 
Lived with a 
problem alcohol or 
drug user 
Y Y Y Y Y Y N Y Y Y Y Y 11 (92%) - 
Household mental 
health issues 
N Y Y Y Y Y N Y Y Y Y Y 10 (83%) - 
Household member 
in prison 
Y N Y Y Y N Y Y N N N N 6 (50%) - 
ACE Total 4 5 9 5 6 5 3 10 3 5 5 2 - 5.17 
(2.329) 
               
SSI-SA 3 3 2 4 3 3 3 3 8 3 3 2 - 3.33 
(1.557) 
PCL-5 0 15 3 4 10 32 13 52 43 58 57 0 - 23.92 
(23.051) 
Dissociative subtype N N N N N N N Y Y Y Y N 4 (33%) - 
            N   
Reexperiencing Y Y Y Y Y Y Y Y Y Y Y Y 12 (100%) - 
Avoidance Y Y Y Y Y Y Y Y Y Y Y N 12 (100%) - 
Dissociation Y Y N Y N N Y Y Y Y N Y 8 (67%) - 
Tobacco use Y Y Y Y Y N Y Y Y Y Y Y 11 (92%) - 
Alcohol use Y Y Y Y Y N Y Y Y Y Y N 10 (83%) - 
Cannabis use Y N Y Y Y N Y Y Y Y Y N 9 (75%) - 
Cocaine use Y N Y Y Y N Y Y Y N Y N 8 (67%) - 
Amphetamine use Y N Y Y Y Y Y N Y N N N 7 (58%) - 
Inhalant use N Y N N N N N Y Y N N N 3 (25%) - 
Sedative use Y N N Y N N N N N Y Y N 4 (25%) - 
Hallucinogen use Y N Y Y Y N N Y Y N N N 6 (50%) - 
Opioid use Y Y Y Y Y N N N Y N Y N 7 (58%) - 
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6.0 Study 2 Results 
6.1 Characteristics of Sample 
 As can be seen in Table 9, two (17%) participants were screened at a moderate to high 
risk of current disordered substance use, which suggests further assessment is required. One of 
these participants did admit to current active substance use whereas the other individual did not. 
One (8%) participant scored at no current risk, and nine (75%) scored at minimal current risk. 
Specific to items endorsed, 11 (92%) participants endorsed having gone for help for drinking and 
drug issues, one (9%) endorsed having their drinking or drug use causing problems with family 
and friends, and all 12 participants endorsed having had a drinking or drug problem at some 
point and having a family member who has had a drinking or drug problem. A few participants 
(three; 25%) indicated that they consider themselves to continue to have a substance use 
problem, even if they were not actively using. 
 For trauma history, all participants indicated experiencing at least one lifetime traumatic 
event on the LEC-5, and were more likely to endorse multiple events. Similarly, all participants 
endorsed experiencing at least one childhood adverse event on the ACE, but were more likely to 
endorse multiple events. Four (33%) participants met the recommended cut-off score for a 
probable diagnosis of PTSD on the PCL-5; these four also met the criteria for the dissociative 
sub-type of PTSD. Interestingly, two other participants also endorsed multiple dissociative 
experiences, although did not meet the recommended cut-off score for PTSD.  
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6.2 Perceived Causal Relations 
 In Table 10, the mean cause and effect PCR ratings can be found between trauma-related 
symptomatology and specific substances. The causal ratings between trauma symptoms or 
between specific substances were not investigated. 
Table 10: Mean Cause and Effect Associations in Study 2 
 Mean Cause 
(SD) 
Mean Effect 
(SD) 
t df p dz 
Reexperiencing 6.640 (2.522) 4.108 (2.693) 2.599 9 .029   .822 
Avoidance 6.079 (3.141) 3.882 (3.041) 1.653 10 .129   .498 
Dissociation 5.487 (3.559) 3.731 (2.917) 1.481 7 .182   .524 
Tobacco 1.242 (3.004) 4.970 (3.619) 3.787 10 .004 1.142 
Alcohol 6.591 (3.821) 6.788 (3.825)   .143 10 .889   .043 
Cannabis 3.685 (3.678) 4.444 (3.567)   .512 8 .623   .171 
Cocaine 3.905 (2.515) 6.571 (3.459) 1.862 6 .112   .704 
Amphetamine 4.861 (2.007) 7.361 (3.181) 2.484 5 .056 1.014 
Inhalants1 4.668 (1.333) 4.668 (1.333) --- --- --- --- 
Sedatives 2.500 (5.00) 6.250 (4.787) 1.567 3 .215   .783 
Hallucinogens 4.875 (3.794) 5.875 (4.973)   .739 3 .514   .369 
Opioids 4.222 (3.600) 6.611 (4.144) 1.081 5 .329   .441 
Note: Mean cause and effect were only asked between trauma-related symptoms and substance use, such 
that questions exploring how trauma-related symptoms causally related to each other were not asked, nor 
were the causal relationships between substances investigated. 
1The inhalants mean cause and effect scores were calculated but the t-test was unable to be performed, as 
the standard error of the difference is 0. 
 
 Reexperiencing was perceived to be significantly more so a cause than effect of 
substance use, t(9) = 2.599, p = .029, dz = .822; results were non-significant in the case of 
avoidance, t(10) = 1.653, p = .129, and dissociative experiences, t(7) = 1.481, p = .182. In 
contrast, use of tobacco, alcohol, cannabis, cocaine, amphetamine-type stimulants, sedatives, 
hallucinogens, and opioids were all perceived to be more so an effect than cause of trauma-
related symptoms, although only tobacco was significant t(10) = 3.787, p = .004, dz = 1.142, and 
amphetamines were trending toward significance.  
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 All 12 participants interviewed provided further elaboration on their PCR ratings in the 
following section. It is important to note that all participants were asked to retrospectively think 
back to when their substance use was at its worst, but for most of these participants, there is no 
defining “worst” period. Many of them were chronic users over very long periods of time, and 
therefore could not meaningfully separate their substance use into discrete “worst” periods.  
6.3 Alan 
 Alan is a 51-year old Caucasian man in a common-law relationship. He is currently 
employed with no psychiatric diagnoses, and has an undergraduate degree. Alan has undergone 
treatment for alcohol, drugs, and codependency, commencing from his last treatment program 
about 20 years ago. He indicated multiple stressful experiences throughout his life, such as 
transportation accidents, serious work injury, exposure to a toxic substance, physical assault, 
assault with a weapon, and witnessing a sudden and violent death when he witnessed an accident 
where “the steering part was sticking out of [the driver’s] chest”. Specific to his childhood, Alan 
endorsed experiencing psychological and physical abuse, and living with someone who was an 
alcoholic. However, he says of his mother’s alcoholism: “I don’t remember her drinking”. While 
he did not live with a member of his household in prison, he himself went to prison many times, 
often for substance-related charges: “I was shipped out many a time … substance, yeah, I can 
always relate any time something went bad with a substance”.  
 Within the past month, Alan did not endorse experiencing any PTSD or TRASC 
symptoms, nor did he report actively using any alcohol or drugs. He indicated on the SSI-SA that 
he is currently going for help because of his drinking and drug use; however, this is specific to 
his past use, not current use. He also indicated on the SSI-SA that both he and family members 
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have had a drinking or other drug problem at some point in their lifetimes. In reference to his 
drug use, he noted: “I did not know how to feel mentally, I knew how to feel chemically from a 
very young age, and when I say young age, I mean probably eight”. When Alan’s substance use 
was at its worst, he indicated using tobacco and alcohol on a daily basis, cocaine-related drugs 
every day for most of the day, amphetamines and sedatives almost daily, cannabis about once a 
week, hallucinogens two or three times, and opioids once in his lifetime. He also endorsed 
reexperiencing, avoidance, and dissociative symptoms daily or almost daily during his worst 
periods of substance use. However, he also attributed most of his dissociative experiences, as 
well as experiences of hallucinations and paranoia, directly to the effects of his drug use, and that 
he was not sure how much was not drug-induced. Nevertheless, when asked about the 
relationships between various substances and trauma-related symptoms, Alan responded that 
“everything I did was avoidance” and that he used substances to “avoid the consequences” of 
both his actions and his trauma.  
Alan’s PCR ratings can be seen in Figure 6. In sum, trauma-related reexperiencing was 
rated as a strong cause of his hallucinogen and opioid use, and a moderate cause of his tobacco 
and amphetamine use. His alcohol use was rated as both a strong cause and effect of 
reexperiencing, and his cannabis use was rated as both a moderate cause and effect of 
reexperiencing. He also reported that avoidance was a strong cause of his cocaine, amphetamine, 
hallucinogen, and opioid use, whereas he attributed his avoidance as a moderate cause of his 
tobacco use. Alan rated alcohol as both a strong cause and effect of avoidance, and cannabis as 
both a moderate cause and effect of avoidance. Lastly, Alan considered his dissociation as a 
moderate cause of his amphetamine use, but a strong cause and effect of his alcohol and cocaine 
use.  
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 Alan further explained his high PCR ratings associating his alcohol use and his trauma-
related symptoms: “I’d say I got to quit this, I got to change my life, and I’d like, a beer, and I’d 
be in the crack house. I did everything I said I’d never do once I started drinking”. In 
comparison, he believed that he “had more control on drugs ... Alcohol would lead me to a loss 
of control and blacking out more so then drugs. Drugs I could manipulate and make work, and fit 
them into the feeling I was trying to get”. He reported: “cocaine was my ticket. That’s where I 
felt the best. When I use cocaine, I had a feeling of invincibility. I was right where I needed to 
be, nothing was negative, everything was positive in my life”. In addition, he felt that 
amphetamines helped: “to escape reality”. Overall, Alan reported self-medicating with more 
substances than he did having the substances cause his trauma-related symptoms. He also 
seemed to endorse using specific substances for specific causes, such that he could moderate his 
alcohol use with drugs “to be less drunk, to combat the way I felt”, and could “create a feeling 
through the substance, the behaviour of the substance and get to where I wanted to be, where I 
felt I needed to be”.   
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Figure 6: Summary of PCR Ratings for Alan in Study 2 
 
6.4 Don 
 Don is a 55-year-old Caucasian man who has been married for almost 30 years. He 
currently has a diagnosis of major depression, has a college diploma, and is employed full-time. 
Don was in treatment for alcohol and drug addiction about two years ago, and has not used since. 
Over his lifetime, Don has experienced a couple of car accidents, a life-threatening illness, and 
witnessed severe human suffering in that “I saw a rape once”. He has also witnessed sudden 
accidental death. Specific to his childhood, Don reported psychological and physical abuse, 
emotional neglect, living with a mother who was a problem drinker, and at least one of his 
household members was mentally ill or suicidal. He spoke of a difficult relationship with his 
father, as his father “was very strict. You just didn’t want to cross him, he would, ah, he would 
hit you and, uh, worse than hitting was that he would sulk at you, and that could go on for days”. 
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 On the PCL-5, Don scored 15 out of 80, indicating that he likely does not currently have 
PTSD. However, he endorsed being moderately bothered by having strong negative beliefs about 
himself, others, and the world as well as by having strong physical reactions at reminders of a 
stressful experience. In regards to the physical reactions, Don reported that: 
  Two years ago, when I was hitting my bottom, this time of year reminds me of it, and I 
 find that kind of stressful, and it’s usually a feeling of anxiety, so kinda shortness of 
 breath. It takes me back to how emotionally low I felt back then. 
Additionally, Don indicated being a little bothered by a marked loss of emotion, but no other 
TRASC symptoms. On the SSI-SA, he endorsed going to meetings, having had a drinking or 
drug problem, and having a family member with a drinking or drug problem, but does not meet 
the recommended score for an investigation into a probable SUD. However, Don does 
“definitely identify as an alcoholic, recovering alcoholic”.  
 Don specified that he had more than one worst period or “rock bottom” where his 
substance use was at its worst, as “I was sober in AA for 19 years, and then went out for like two 
years, so I’m back for two years. So, um, there is kinda two bottoms”. For the purposes of 
causally relating trauma symptoms to his substance use, he decided to combine the two periods 
in his mind. When Don’s substance use was at its worst, he reported using alcohol daily or 
almost daily for most of the day, tobacco and opioids multiple times daily or almost daily; he 
used inhalants two or three times in his lifetime. He also reported having trauma-related 
reexperiencing and avoidance about daily or almost daily, and dissociative experiences two or 
three times during these periods, although he indicated that the dissociation was likely drug-
induced. Don’s PCR ratings can be found in Figure 7. 
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 When asked to make causal connections between his tobacco use and trauma-related 
symptoms, Don endorsed reexperiencing as a strong cause of his inhalant use and a moderate 
cause of his tobacco use. His reexperiencing was also rated as a strong cause of his alcohol use 
and his alcohol use a moderate cause of his reexperiencing, whereas his reexperiencing was rated 
as a strong cause of his opioid use and his opioid use was rated as a mild cause of his 
reexperiencing. Don perceived his avoidance to be a strong cause of his tobacco use, whereas his 
tobacco use was a moderate cause of his avoidance. Similarly, his avoidance was perceived to be 
both a strong cause and effect of inhalant use, and alcohol was perceived as both a moderate 
cause and effect of avoidance.  
 In general, Don reported that his tobacco, alcohol, inhalant, and opioid use were caused 
by reexperiencing and avoidance, such that he reported self-medicating his trauma symptoms 
with these specific substances. In fact, Don reported self-medicating more than just his trauma 
symptoms: “that’s the thing with me, there wasn’t just one stressful experience. With me, it was 
also like feelings of inadequacy that alcohol took away, um, and although I was diagnosed with 
anxiety and depression a couple years ago, I’m sure I suffered from that in the past and self-
medicated it”. Don’s inhalant use was perceived to be equally a cause and effect of avoidance, 
and his alcohol and inhalant use were perceived to be stronger causes of dissociative experiences 
than dissociative experiences were of alcohol and inhalant use. 
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Figure 7: Summary of PCR Ratings for Don in Study 2 
 
6.5 Craig 
 Craig is a 54-year-old Caucasian man who is currently single and self-employed. He has 
never had a psychiatric diagnosis, and never finished high school. He was in treatment for 
alcohol and drugs, and commenced from his last treatment program about seven years ago. Craig 
indicated experiencing many stressful experiences over his lifetime, such as a fire or explosion, 
transportation accident, serious work injury, physical assault, assault with a weapon, and 
witnessing a sudden accidental death. Of the accidental death, he stated, “found one of our 
members in our rooms …. drank himself to death. That was just this past year”. Specific to his 
childhood, he endorsed experiencing psychological and physical abuse, emotional and physical 
neglect, having parents separated, mother abused, living with problem alcoholics or drug addicts, 
having at least one family member suicidal and mentally ill, and having a family member go to 
prison. He said of trying to count the number of family members who went to prison, “you’re 
better off [counting] which ones didn’t go”. Craig came from a family with 12 siblings, and said 
of his childhood:  
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 We had lots of foster homes. I don’t know how many times the old man sold everything 
 but his TV and a couple bags of clothes and away we’d go back to BC or Ontario. 
 Whenever my mom left, my dad’ve had a few months reprieve, and then we’d go chase 
 her down.  
In the past month, Craig endorsed a total of three out of 80 on the PCL-5 with being moderately 
bothered by concentration difficulties and a little bit bothered by feeling jumpy or easily started. 
There was no endorsement of any TRASC items. On the SSI-SA, Craig endorsed no substance 
use in the past month, and only indicated yes on the items asking about ever having a drinking or 
drug problem for himself and for family members. However, when his substance use was at its 
worst, Craig endorsed using tobacco, alcohol, cannabis, cocaine, and hallucinogens daily or 
almost daily for most of the day, and amphetamines daily or almost daily. Also during this period 
of time, he endorsed the trauma-related symptoms of reexperiencing and avoidance daily or 
almost daily, but no dissociative experiences. He says of his difficulties describing the frequency 
of his reexperiencing, “all it took was the wrong kind of conversation with someone to bring it 
up, so it’s hard to find the right number for it”. When asked to rate the causal relations between 
his substance use and trauma-related symptoms, he could only make sense of the relationships 
between tobacco and alcohol use, as ecstasy was more of a “if it was there, it was there. If 
someone walked in the room and that was all they had, that’s what we used” and “any of the 
other ones were just part of the atmosphere, just what we were going to do that night”.  
 The PCR scores for tobacco and alcohol can be found in Figure 8. In sum, Craig 
perceived his trauma-related reexperiencing to be strongly causal of his alcohol use, and he 
perceived that his alcohol use was strongly causal of reexperiencing. Reexperiencing was also 
perceived to be mildly causal of tobacco use. Lastly, Craig rated his avoidance as a strong cause 
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of his substance use. When Craig discussed his alcohol use in relation to it causing his 
reexperiencing, he said: 
 If I didn’t drink, it didn’t bother me on a daily basis. If I drank, which I drank everyday, 
 but then you got to remember where that state of drinking it. By midday, if I got six or 
 eight beers in me, well, it doesn’t bother me, but later in the evening, when you got that 
 much more in you, my self worth and all those kind of issues surfaced because “why me, 
 why me”. They would surface more stronger when I had more booze in me.  
He elaborated with, “Like, I drank every day, all day, but I wasn’t drunk every day, all day. But 
when I got to my, uh, end of day kind of state and my childhood issues would surface big time.” 
Craig seemed to have a threshold in which alcohol in the right amount could self-medicate, but 
any more than that and the alcohol would bring about his childhood issues and reexperiencing.  
Figure 8: Summary of PCR Ratings for Craig in Study 2 
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6.6 Dylan 
 Dylan is a 26-year-old Caucasian man who is currently single and unemployed. He has 
been attending adult education to finish his high school diploma, and reported no past or current 
psychiatric diagnosis. However, later in the interview, he alluded to a past diagnosis of 
depression. Dylan has been out of treatment for alcohol and drug addiction for one year. He 
endorsed experiencing multiple stressful events over his lifetime, including a transportation 
accident in which he was knocked out, physical assault where he had “been stabbed, had [his] 
teeth knocked out”, assault with a weapon and “gotten bottled”, life-threatening injuries as a 
result of assault with a knife, and causing someone else serious injury or harm because he 
“assaulted a lot of people in active addiction”. In response to the open-ended item on the LEC-5 
about any other stressful experience, he reported that many of his family members and close 
friends have overdosed, died, or disappeared for large periods of time. Specific to his childhood 
experiences, Dylan endorsed being psychologically abused by his uncle who raised him, 
emotionally neglected, living with an alcoholic or addict, living with a member of the household 
who was mentally ill, and living with a uncle who was in and out of prison. However, Dylan 
specifies that “my uncle …. Not prison I guess, he would just go to jail on weekends. I’ve done 
most of the jail time in my family I guess”.  
 On the PCL-5, Dylan scored a four out of 80, therefore far below the recommended cut-
off score for a probable diagnosis of PTSD. He reported that he was a little bit bothered by 
having strong negative beliefs, having strong negative feelings, feeling irritable or acting 
aggressively, and taking too many risks. The negative beliefs and feelings were mostly directed 
at the trauma of being abandoned by his sister: “I have negative thoughts about, I ran into my 
little sister last week. She’s in active addiction. She’s got endocarditis, it affected me a little bit. I 
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have negative feelings toward [her]”. He also said, “I had PTSD, I’ve done counseling”. He also 
reported no current TRASC symptoms. On the SSI-SA, Dylan indicated attending meetings to 
help with his recovery, and that he has had a drinking or drug problem, as have at least one 
family member. He also endorsed the item about drinking or drug problems causing problems 
between himself and family or friends: “My uncle’s an alcoholic, sister is a drug addict 
alcoholic. Most of the people I grew up with and consider family are alcoholics or drug addicts. I 
don’t talk to them anymore”.  
 When his substance use was at its worst, Dylan endorsed using tobacco, sedatives, 
hallucinogens, and opioids daily or almost daily for most of the day, cocaine and amphetamines 
multiple times daily or almost daily, alcohol about once per week, and cannabis about two or 
three times during this period. He said of this time: “I was pretty much high for 10 years”. Derek 
also endorsed reexperiencing and avoidance symptoms as occurring daily or almost daily for 
most of the day, and dissociative experiences about daily or almost daily during the period of 
time when his substance use was at its worst.  
 Dylan’s PCR ratings are in Figure 9. He endorsed strong causal relationships between all 
three trauma-related symptoms and tobacco, alcohol, cocaine, amphetamines, sedatives, and 
hallucinogens, saying “these are pretty much all going to be 10”. Dylan specified that only 
cannabis was not a strong cause or effect of his trauma-related symptoms. He perceived his 
reexperiencing as a mild cause and effect of cannabis use, but there was no relationship between 
cannabis and avoidance or dissociation. When asked to clarity why he said almost all of his 
substance use was strongly caused by and a cause of his trauma-related symptoms, he said that 
he bounced from substance to substance because “it was just substitution. They all worked until 
they didn’t work [at suppressing trauma symptoms], and then I tried something new. It’s just 
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substitution”, suggesting he used substances until he gained tolerance, and then he moved on to 
something new.  
 In Dylan’s case, his PCR ratings did not give a clear indication of whether or not he self-
medicated his trauma-related symptoms. However, when prompted to elaborate, he did endorse 
self-medicating with his aforementioned explanation on substituting drugs when the ones he was 
on stopped doing what he was taking them for.  
Figure 9: Summary of PCR Ratings for Dylan in Study 2 
 
6.7 Daniel  
 Daniel is a 60-year-old Caucasian man currently divorced and diagnosed with depression. 
In the past, he was in a snowplow accident that left him with a traumatic brain injury and some 
memory loss, but he reported that he felt “lucky to be alive”. Over his life, Daniel has witnessed 
fires and been near multiple tornados, been physically assaulted, and witnessed a violent death. 
  
73 
He was a volunteer fireman and “saw some pretty awful things”. Specific to his childhood, he 
reported psychological abuse, emotional neglect, and growing up with an alcoholic father. His 
dad “was an alcoholic. [He] was sexually abused for years, so [he] was depressed”. Daniel 
scored only seven on the PCL-5, far below the recommended cut-off score of 38 for a probable 
diagnosis of PTSD for the past month. He did however endorse being quite a bit bothered by 
repeated disturbing dreams of his past stressful experiences.  
Having finished treatment five days prior to the interview, Daniel did not endorse using 
any substance use within the past month. However, Daniel has a lifetime history of using 
alcohol, tobacco, cannabis, cocaine, amphetamine-stimulants, hallucinogens, and opioids during 
multiple periods of his life: “I started drinking at the age of 13 to the age of, well, I’ll say 60. I’ve 
relapsed I couldn’t tell you how many times – lots”. He also said, “I’ve done every drug 
imaginable … and I’m not ashamed to admit it”. The PCR ratings between Daniel’s endorsed 
substance use and trauma-related symptoms during the periods of time where his substance use 
was at its worst can be seen in Figure 10. Due to the nature of his traumatic brain injury, Daniel 
had difficulties remembering discrete periods of substance use, and so he was not always able to 
identify when he was using specific substances or which period was when his substance use was 
at its worst. As such, he spoke about all of his periods of substance use. In brief, PCR ratings 
varied significantly by substance class. Daniel’s reexperiencing was a perceived to be a strong 
cause and effect of his alcohol use, and perceived to be a mild to moderate cause and effect of his 
cocaine, amphetamine, hallucinogen, and opioid use. However, he perceived that his 
reexperiencing was strongly caused by tobacco use. Daniel’s avoidance was reported to be a 
strong cause and effect of his alcohol use, as well as moderate cause moderate of his cannabis 
and cocaine use. Cannabis and cocaine were also perceived to be moderately and mildly causal 
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of his avoidance, respectively. Lastly, his avoidance was perceived to be a moderate cause of his 
amphetamine and hallucinogen use whereas he considered his amphetamine use to be a mild 
cause of his avoidance, and he perceived that his avoidance mildly caused his opioid use and his 
opioid use moderately caused his avoidance. Overall, in the past Daniel had been self-medicating 
his trauma-related symptoms with tobacco and opioids, but an increased severity of 
reexperiencing and avoidance of stressful experiences may have been caused when he used other 
substances such as cannabis and amphetamines.  
Figure 10: Summary of PCR Ratings for Daniel in Study 2 
 
6.8 Sarah  
 Sarah is a 30-year-old Caucasian woman who is currently single and unemployed. She 
was diagnosed with an anxiety disorder in the past, and has completed some college or university 
courses. She says of her anxiety, “I obviously [felt] extreme anxiety when trying not to use 
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drugs”. She attended treatment for both addiction and codependency, and it has been seven 
months since she has used substances. She will be entering into a program for maintaining 
sobriety in the near future. On the LEC-5, Sarah endorsed experiencing a transportation accident, 
serious accident at work, exposure to toxic substances, physical assault, unwanted sexual 
experiences, emotional captivity by an ex lover, life-threatening illness (attempted suicide three 
times), witnessing severe human suffering, and that she had caused someone else serious injury 
or harm. Sarah indicated being unsure about a sexual assault, due to her circumstances: “When 
you're using, whenever you’re doing stuff; I don’t feel like it was [rape] but at the same time, 
like, at certain points …. I don’t feel like it’s forceful in any way, but …. Now that I’m not using 
…”. On the open-ended last question, Sarah described her trauma on becoming pregnant while 
on drugs and having her child removed from her care when she relapsed. Specific to her 
childhood, Sarah reported psychological abuse, emotional and physical neglect, living with a 
problem alcoholic, and living with a mentally ill family member. For example, “I went to every 
party with my mom, mostly drinking, um, but still there’d be times I’d get in the car scared we 
were driving home”.  
 Sarah scored 32 out of 80 on the PCL-5, which is just below the recommended cut-off 
score of 38 for probable PTSD. With the 10 TRASC items, her score was 36 out of 120. She 
endorsed feeling quite a bit bothered by repeated and disturbing memories, repeated and 
disturbing dreams, feeling distant or cut off from people, having trouble experiencing positive 
feelings, and trouble falling or staying asleep. She reported being moderately bothered by feeling 
upset at reminders, having strong physical reactions to reminders of trauma, blame, strong 
negative feelings, loss of interest in activities, and having difficulties in concentrating. She 
reported some difficulty in responding to these questions, such that “I can’t focus on them, 
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because they, like … because [the items]’s are so deep, I start, like, it doesn’t like it or something 
in my brain.” For TRASC, she endorsed feeling a little bothered by flashbacks, feeling like what 
she is experiencing is not real, out of body experiences, and identity confusion such that “I feel 
like I put on many masks, still, and not intentionally” because she has had many different roles 
and jobs in her life. On the SSI-SA, Sarah did not meet the criteria for further investigation into a 
probable SUD diagnosis, although she endorsed going to meetings to maintain her sobriety, 
having had a drinking or drug problem, having a family member with a drinking or drug 
problem, and feeling as though she currently has a drinking or drug problem. 
 When Sarah’s substance use was at its worst, she reported using amphetamines daily or 
almost daily for most of the day. Additionally, she reported experiences of reexperiencing and 
avoidance daily or almost daily for most of the day. When endorsing avoidance, without 
prompting, she said “well, that’s why I would do the drugs I guess”. She said of her substance 
use, “it was more like, I made it for what I want[ed] it to be, like, you would avoid everything 
and I would just do what I want”. Sarah’s PCR ratings can be seen in Figure 11. She endorsed 
both reexperiencing and avoidance as strong causes and effects of her amphetamine use. When 
elaborating on the relationship between amphetamine use and reexperiencing, she said:  
 It would create worse [dreams] …. But when I stopped using, the reason I have those 
 dreams is because I felt like literally it’s filing everything I didn’t file because I didn't 
 sleep ever. It made me stop, but it created a ton more …. Now it’s just overwhelming, 
 and is just a cycle on its own.  
Similarly, “it wasn’t always about the thoughts, but what do I do now … I need to reuse again to 
get to where I [need to go]”. She did not report any dissociative experiences during this time 
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period, but did subsequently report a mild causal relationship with amphetamine and 
dissociation. It is evident from her PCR ratings and elaborations that her amphetamine use was 
likely very cyclical with being a cause and an effect of the trauma-related symptoms of 
reexperiencing and avoidance. 
Figure 11: Summary of PCR Ratings for Sarah in Study 2 
 
6.9 Derek 
 Derek is a 27-year old Caucasian man. He did not wish to provide other details about his 
psychiatric diagnoses, education, or when he commenced from his treatment program for 
substance use. However, at one point, Derek mentioned that he has not used substances in 45 
days. He endorsed experiencing multiple stressful events in his life, specifically, being hit by a 
car, being physically assaulted and “jumped a couple times and, I don’t know, about 50 fights I 
guess”, accidentally ingesting a toxic substance, and causing serious injury or harm to others 
during the numerous fights he has participated in. He mentions that “I enjoy the adrenaline rush, 
or I used to, I guess” and “I didn’t lose a lot [of fights]”. Derek also reported that, during his 
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childhood, his father, a drug addict, went to prison or chose to do drugs, of which he says “I 
always felt he didn’t love me because of that.” Additionally, he described: 
 When I was 16, I seen [dad’s] drug use; that kind of traumatized me a little bit. I 
 watched him injecting heroin and smoking speed. He showed me how to make a light 
 bulb into a speed pipe. Smoked a doobie with me, it was my first doobie ever, with many 
 more to follow. 
Derek scored 13 out of 80 on the PCL-5, therefore failing to meet the cut-off score for a likely 
diagnosis of PTSD. Derek endorsed being moderately bothered by irritability or anger in the past 
month, but endorsed being bothered only “a little bit” over the same time period by unwanted 
dreams and memories, feeling upset at reminders, avoidance of both internal and external 
reminders, having strong negative beliefs, blaming himself, having strong negative feelings, 
having trouble experiencing positive feelings, and taking too many risks; however, none of these 
endorsements meet the criteria for the symptom being present currently. On the 10 TRASC 
items, he endorsed being moderately bothered by out of body experiences, commenting: “I was 
up … I felt like I was in space looking down on the world”. He also reported being “a little bit” 
bothered by feeling as though part of his body is not his own and divided or multiple senses of 
self. 
 In the past month, Derek did not indicate any substance use; he has been attending 
meetings, and did not meet the criteria for a current SUD on the SSI-SA. However, when his 
substance use was at its worst, Derek reported using tobacco almost daily for most of the day, 
using cannabis multiple times daily, using alcohol almost daily, and using cocaine or 
amphetamines about once a month. He mentioned that his worst period of substance use was 
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“within the last year, I guess, ‘cause that’s when I started using hard drugs”. During this time 
period, he also indicated that he was experiencing the trauma-related symptoms of dissociation 
about once per week, avoidance of stressful events two to three times, and reexperiencing once 
in his lifetime. When asked about how he thought his trauma-related symptoms related to his 
substance use, he reported that he used substances “to numb things, yeah, yeah, to numb things 
and to keep partying”. Derek’s PCR ratings between these symptoms can be seen in Figure 12.  
 In general, Derek rated his dissociation as a strong cause of his cocaine and amphetamine 
use, but also rated his cocaine and amphetamine use as moderate causes of his dissociation. He 
reported that his alcohol and cannabis use were both moderate or strong causes and effects of his 
dissociation, respectively. Derek stated that his reexperiencing and avoidance ratings were 
similar to his dissociative ratings but no other ratings were collected. Unfortunately, no 
additional questions were asked to clarify this statement. Although he did not give specific 
ratings for how these substances related to reexperiencing and avoidance, he reported that it was 
about the same as the dissociation ratings, in that his substance use was both a cause and an 
effect of his reexperiencing and avoidance.  
 Overall, Derek perceived his past substance use and trauma-related symptoms as having a 
cyclical relationship for the case of alcohol and cannabis use and dissociation. He rated that both 
his alcohol and cannabis use and his dissociation were equally a cause and an effect of each 
other. However, his ratings for cocaine and amphetamine use indicate that he seems to use these 
substances to self-medicate his dissociative experiences. 
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Figure 12: Summary of PCR Ratings for Derek in Study 2 
 
6.10 Barry 
 Barry is a 44-year-old Caucasian single, unemployed man. He reported that he had nearly 
completed high school, and in the past, has indicated psychiatric diagnoses of anxiety, 
depression, and PTSD. He has been through treatment for alcohol and drug abuse multiple times, 
completing his latest treatment two months prior to the present research interview. Barry 
reported experiencing many lifetime stressful events, including a tornado, exposure to toxic 
substances such as “fumes and gases and … asbestos”, physical assault, assault with a weapon, 
an unwanted and uncomfortable sexual experience, being in captivity or held against his will by 
a family member, life-threatening injuries such that he was “stabbed six times” with internal 
bleeding, witnessed severe human suffering during his addiction, and caused another person 
serious injury or harm “all in self-defense”. He also tried to commit suicide at least once, as he 
“drank a bunch of bleach there a couple years ago and lived”, has almost drowned, and recently 
learned that his sisters had been molested when they were younger. On the ACE measure, he 
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indicated in the affirmative to all ten adverse childhood experiences listed. He often felt 
psychological and physical abuse, emotional and physical neglect, his parents were separated and 
“we were separated from them too”, his mother was physically assaulted multiple times by his 
father, his immediate and extended family all abused alcohol or drugs, and his father was in and 
out of prison “constantly”. With regard to the level of mental illness and suicidal tendencies 
within his family he described: “I think we all tried to drink ourselves to death at some point in 
my family”. 
 On the PCL-5, Barry scored 52 out of 80, well above the recommended cut-off score for 
a probable diagnosis of PTSD. Including the 10 TRASC items, his total score was 73 out of 120. 
Of the 20 PCL-5 items, his highest rated symptoms involved extreme issues with being bothered 
by strong negative feelings, aggression, being “superalert”, feeling “jumpy”, concentration 
difficulties, and sleep disturbance. On the TRASC items, he indicated being extremely bothered 
by difficulties with loss of emotional feeling, identity confusion, and losing time for periods of at 
least 10 minutes. In the past month, he indicated no active addiction other than to using 
marijuana to manage some symptoms. On the SSI-SA he noted that he currently attends 
addiction support meetings to help maintain his sobriety, and endorsed that he and family 
members have had a drinking or drug problem, but did not score for a likely diagnosis of a 
current substance use disorder. 
 When Barry’s substance use was at its worst, he indicated using tobacco, alcohol, 
cannabis, and cocaine multiple times daily or almost daily, as well as inhalants and hallucinogens 
two to three times. Also during this period, Barry rated the trauma-related symptoms of 
reexperiencing and dissociation as having been present about daily or almost daily, and 
avoidance symptoms as daily or almost daily for most of the day. In terms of the causal 
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relationships between his substance use and trauma-related symptoms, Barry rated his inhalant 
and hallucinogen use as having no relationship with reexperiencing, avoidance, and dissociation. 
Inhalants were “something I tried, I wouldn’t say there is anything for inhalants” and 
hallucinogens were “just for the smile on the face, relaxing”. However, he perceived that his 
tobacco, alcohol, cannabis, and cocaine use were all related to his trauma-related symptoms. His 
PCR ratings can be found in Figure 13.  
Referring first to his trauma-related reexperiencing, Barry reported reexperiencing as a 
strong cause of his tobacco use, and that both reexperiencing was both a strong cause and effect 
of his alcohol use. He says of his alcohol use and reexperiencing, “sometimes I’d have to [drink] 
to feel normal”. Similarly, reexperiencing was rated both a moderate cause and effect of his 
cannabis and cocaine use. In reference to Barry’s avoidance, he considered it to be a strong cause 
and effect of tobacco, alcohol, and cannabis use. He said of the nature of the relationship 
between his alcohol use and avoidance symptoms, “I’d try to avoid with drinking, you know 
what I mean, it would just work on both ends, it was the answer to everything”. He reported that 
his avoidance symptoms were a moderate cause and effect of his cocaine use as well. Lastly, in 
reference to his dissociative experiences, Barry attributed his dissociation to be a strong cause of 
his tobacco and cocaine use. He also rated dissociation as a strong cause and effect of his alcohol 
use, and a moderate cause but strong effect of his cannabis use. 
 Overall, in past periods of his life, Barry seems to have entered into a cycle where his 
trauma-related symptoms of reexperiencing and avoidance would lead him to drink, and drinking 
would also cause him to experience further trauma symptoms. Similarly, he considers his 
cannabis use to be a somewhat strong factor in his trauma-related avoidance behaviour. In the 
case of his use of tobacco, alcohol, and cocaine, he considers dissociative experiences to be more 
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likely causes of his substance use than vice versa whereas, in reference to his cannabis use, Barry 
considered the opposite to be true: he believed that his cannabis use was more so a cause of his 
dissociative experiences.  
Figure 13: Summary of PCR Ratings for Barry in Study 2 
 
6.11 Eric 
 Eric is a 60-year-old man who is Caucasian, divorced, and retired. He has some college 
or university experience, and is currently diagnosed with depression, anxiety, and PTSD. Eric 
has been out of treatment for a substance use disorder, but admitted to currently using 
substances. He reported experiencing numerous lifetime stressful events, such as transportation 
accidents, a serious accident where “I broke my leg, then it got infected … I almost lost my leg”, 
assault with a weapon where “a fella did pull a revolver out”, sexual assault in adulthood, other 
unwanted or uncomfortable sexual experiences where “when I get high, I lose my inhibitions and 
do degrading acts”, and captivity. On the open-ended item on the LEC-5, Eric mentions being 
videotaped against his will. Eric also reported experiencing childhood adversity with divorced 
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parents, living with a problem drinker or drug addict, and having a household member who was 
mentally ill or suicidal, but otherwise said “I had a pretty good childhood” even though “my 
father abandoned our family when I was 17”.  
 Overall, Eric scored 43 out of 80 on the PCL-5, but with an additional score of four on 
the TRASC items. He meets the criteria for current PTSD, which reflects his current diagnosis as 
mentioned earlier. His highest rated symptoms include feeling extremely bothered by disturbing 
and unwanted memories, flashbacks, having strong negative beliefs, and having strong negative 
feelings.  
 On the SSI-SA, Eric met the criteria for being at a moderate to high risk of substance use 
problems and should be assessed further for an SUD; he scored eight out of 14. During the 
interview, he admitted to currently using, as “before I only had lapses, but since coming out of 
treatment, I’ve had relapses … I’ve got to change my behaviour” but also says that he is lucky 
that “I’ve got a real supportive family, kids … they’re 100% behind me”. He also said of his 
family: “I’ve been open with them ... they understand that this is a process”. When his substance 
use was at its worst, Eric reported using tobacco multiple times daily or almost daily, 
amphetamines daily or almost daily, cocaine and opioids about once per week, and alcohol, 
cannabis, inhalants, and hallucinogens two or three times. Eric said, “I never had a drug problem 
prior to two years ago, and then my life turned upside down and everything” when he started 
“using them at times to avoid dealing with life issues and dealing with pain”. He mentions that 
“quite often I didn't know what I was getting” when he was buying drugs, and so his frequencies 
may not be fully accurate. He also endorsed reexperiencing and avoidance as occurring once per 
week, although he admits, “I didn't think I used to avoid”. Eric’s PCR ratings can be seen in 
Figure 14.  
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 When asked about the causal relations between trauma-related symptoms and substance 
use, he said “to me, I would have been high, and not in a condition to [make judgments]”. 
However, to the best of his ability, Eric rated his reexperiencing symptoms as strong causes of 
tobacco and amphetamine use, although amphetamine use was also rated as a strong cause of his 
reexperiencing. His reexperiencing was also perceived to be a moderate cause of his cocaine and 
inhalant use, although his cocaine and inhalant use were perceived to be mild and moderate 
causes of his reexperiencing, respectively. However, Eric perceived his reexperiencing to be 
mildly caused by his hallucinogen use and moderately caused by his opioid use. In terms of his 
avoidance, Eric perceived avoidance to be a strong cause of tobacco and amphetamine use, and 
his amphetamine use was perceived to be a strong cause of his reexperiencing. Avoidance was 
also rated as a moderate cause of his cocaine and inhalant use, whereas his cocaine use was rated 
as a mild cause and his inhalant use a moderate cause of his avoidance. Similar to 
reexperiencing, Eric reported that his avoidance was moderately caused by opioid use, and 
mildly caused by his hallucinogen use. Lastly, his dissociative experiences were perceived to be 
moderately caused by his inhalant use and mildly caused by his amphetamine and hallucinogen 
use. 
 When he was talking about the differences in his PCR ratings, he explained that, “if I 
inject, it’s a stronger feeling than inhaling”. However, it is evident that for reexperiencing and 
avoidance, either the trauma symptoms were a strong cause or a strong effect, based on the drug. 
However, for Eric’s dissociative experiences, dissociation was always caused by his use of 
amphetamines, hallucinogens, and opioids. 
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Figure 14: Summary of PCR Ratings for Eric in Study 2 
 
6.12 Matt 
 Matt is a 51-year-old university-educated Caucasian man currently two months into his 
treatment program for substance use. He is unemployed, separated “although he and his wife 
have not been in contact since the marriage broke up seven years ago”, and has current diagnoses 
of depression, anxiety, PTSD, and major dysthymia. Matt reported experiencing numerous 
lifetime stressful experiences on the LEC-5, such as a natural disaster in the form of an ice storm 
where “the army was policing the streets, people were out of power for a week”, a transportation 
accident, multiple serious accidents at work including at least five concussions, exposure to a 
toxic substance, physical assault and assault with a weapon. Matt also endorsed multiple sexual 
assaults in childhood by a paternalistic figure outside of the home where he said that he was 
“easily the twentieth person to come forward with charges against him” and “it’s only been in the 
last few years where I have acknowledged this in any way”. The figure was a notable public 
figure in his city, and he also reported feeling traumatized and betrayed by the elders in the 
  
87 
community who were aware of this happening but “felt that they might be held personally 
financially responsible” and so did not come forward. He also endorsed witnessing the aftermath 
of a sudden violent death where a woman he was in a relationship died in his home: “one 
morning I found her dead. She had died falling in my bathroom, she had died falling drunk”. On 
the open-ended question, Matt mentions coming to terms with the trauma of his addiction and the 
consequences of it, enhanced by the death of his loved one. During his childhood, Matt endorsed 
experiencing five items on the ACE: psychological abuse such that “I lived under the belief that I 
could be hurt by my father” which was further heightened by the “distrust of patriarchal 
figure[s]” from his sexual abuse, sexual abuse by a trusted elder, emotional neglect, livings with 
a problem alcoholic or drug addict, and living with a household member who was mentally ill.  
 On the PCL-5, Matt scored 58 out of 80, and he also had a high score of 28 on the 
TRASC items. He meets the criteria for a likely diagnosis of both PTSD and its dissociative 
subtype. He reported feeling extremely bothered by feeling upset at reminders, avoidance of both 
internal and external reminders, having strong negative feelings, being “superalert”, and an 
altered sense of time. He also reported being bothered quite a bit by repeated and unwanted 
memories, flashbacks, strong negative beliefs, blaming self or others, feeling distant or cut off, 
trouble experiencing positive emotions, feeling jumpy, concentration problems, derealization, 
out of body experiences, divided senses of self, lost time (amnesia), and hearing voices.  
 On the SSI-SA, Matt scored as a minimal risk, endorsing going for help, having had and 
currently having a substance problem as well as having a family member with a substance 
problem. When his substance use was at its worst, Matt reported using tobacco and alcohol daily 
or almost daily for most of the day, and sedatives multiple times daily. He also used cannabis 
about once a week because even though he “had no craving for cannabis” he used it “as a kind of 
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substitute for, say, going to [unnamed] detox”. He endorsed reexperiencing and avoidance 
symptoms as occurring daily or almost daily for most of the day, and dissociative symptoms 
multiple times daily although he said the dreamlike state of derealization he was experiencing 
was “invariably” caused by substance use.  
 Matt’s PCR ratings can be found in Figure 15. He said of attempting to make causal 
connections between his trauma-related symptoms and his substance use: “Well it’s difficult to 
know because, I, uh, that's demanding a degree of objective judgment that I think I probably did 
not have”. In sum, all three of his trauma-related symptoms strongly caused his tobacco use and 
moderately caused his cannabis use. He says of his tobacco use and trauma-related symptoms, 
“on the one hand, I experienced reexperiencing when I was using tobacco products. On the other 
hand, I have not been using tobacco products since arriving here ... and yet I continue to have all 
of these symptoms”. Additionally, all three trauma-related symptoms were reported to be a 
strong cause and a strong effect of his alcohol use, but that “my memory of it will be severely 
distorted. I would say, alcoholism for me … I really do get into chicken and egg” and so he was 
“loathe to put an objective” value on these relationships. Lastly, both reexperiencing and 
avoidance were perceived to be moderate causes of his sedative use. As such, Matt endorsed the 
self-medication hypothesis for tobacco, cannabis, and sedatives, but perceived his alcohol use to 
be cyclical in that it was caused by while also a cause of his trauma-related symptoms. 
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Figure 15: Summary of PCR Ratings for Matt in Study 2 
 
6.13 Jordan 
 Jordan is a 29-year old mixed race man who is in treatment for substance use. He is not 
currently employed, is single, and has some college or university education. In the past, Jordan 
reported being diagnosed with generalized anxiety disorder, depression, and schizophrenia, 
although he said “the schizophrenia was drug-induced”. Jordan endorsed experiencing 
transportation accidents, physical assault “while on drugs and off”, sexual assault, other 
unwanted sexual experiences, captivity, witnessed a sudden violent death. Under the other 
category, Jordan mentioned childhood experiences such that “mom and dad divorced, I felt a 
little emotionally neglected”, although this is also reported on the ACE. Specific to the ACE, 
Jordan endorsed sexual abuse “at the age of 14”, physical neglect, parental divorce, living with 
an alcoholic or drug addict, and living with a mentally ill household member, such that “my 
mom, after the divorce, was depressed, drinking, hospitalized”.  
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 Jordan currently meets the recommended cut-off score for a likely diagnosis of PTSD, as 
he scored 57 out of 80 on the PCL-5. He also scored 14 on the TRASC items. He reported being 
extremely bothered by repeated and disturbing memories, feeling upset at reminders, having 
strong negative beliefs, blaming himself or others, having strong negative feelings, having 
trouble experiencing positive feelings, and feeling irritable or angry. He said of a piece of 
clothing similar to his attacker’s when he was sexually assaulted: “I walked past the bedroom 
last Friday, and my friend’s sweater … my mind filled in the blank and I felt under attack”. 
Specific to TRASC, Jordan reported being quite a bit bothered by flashbacks, loss of emotional 
feeling, derealization, and losing time for periods of ten or more minutes (amnesia). He also said 
“I did isolate a lot towards the end, when I was at my worst”, which he admitted made his 
symptoms worse. 
 As Jordan is currently in an abstinent-only treatment program, he is not currently using 
substances and scores a minimal risk of substance abuse with 3 out of 14 on the SSI-SA. He 
endorsed going for help, having had a problem with substance use, currently having a problem 
with substance use, and having a family member with problem substance use. He says of his past 
substance use, “It was the best way I know how [to manage] at the time”, “Drugs made me feel 
safe, soothing”, and “It was to self-medicate, soothe, to comfort”. When his substance use was at 
its worst, Jordan was using tobacco, alcohol, cocaine, sedatives, and opioids daily or almost daily 
for most of the day, and cannabis about or almost daily. Also during this time period, he 
endorsed reexperiencing as occurring once per week and avoidance two or three times. He said 
that “I didn’t think about the sexual assault [consciously], but I would be worried about my 
safety”. Figure 16 details Jordan’s PCR ratings between his substance use and trauma-related 
symptoms. 
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 At the beginning of the PCR causal relations questioning, Jordan rated his reexperiencing 
and avoidance to be strong causes of tobacco and sedative use, and mild to moderate causes of 
his alcohol, cannabis, cocaine, and opioid use. He says of his tobacco use: “It sometimes caused 
me anxiety” but that “it didn’t trigger my trauma or any event”, and that his alcohol use was “a 
distraction”. However, upon further reflection, Jordan said of attempting to make the causal 
connections between his substance use and trauma-related symptoms: “It’s hard for me to say. 
This is getting confusing for me because … anytime that I would get upset, sure, I would 
probably get high … I had a false sense of happiness [on drugs]” but that “I didn’t even think 
about this” in reference to attempting to create these causal connections. He then changed his 
answers to have all three trauma-related symptoms to be strongly causal of all of his substance 
use, and reported than none of his substances caused his trauma-related symptoms. He said of 
this change: 
 Learning now what we are learning in treatment, I know that even though I didn’t… it’s 
 so buried and so forgotten and locked away that I didn’t realize that I’m, you know, I’m 
 more predisposed to addiction and I, um, I didn’t realize [PTSD symptoms] has to do 
 with my addiction. 
Jordan further reported that he felt:  
 Predisposed to addiction through PTSD, and I know that now, I see how much it bled into 
 every other area of my life, you know, relationships, job, school, drugs, crime, sex, really 
 everything. It's affected everything, and I didn’t know that … I blame my whole life on 
 the thing that happened when I was 14 [sexual assault]”.  
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Figure 16: Summary of PCR Ratings for Jordan in Study 2 
 
6.14 Kyle 
 Kyle is a 65-year old Caucasian man who is currently married and working full-time. He 
obtained a college diploma, and has never had a psychiatric condition as diagnosed by a 
clinician. Kyle reported experiencing no specific stressful event on the LEC-5, although under 
the “other category”, he classified his brother’s suicide. He said, “I haven’t witnessed [a death], 
but my brother killed himself”. Specific to the ACE, Kyle endorsed living with a problem 
drinker (“my older brother”), and having a family member commit suicide (“my other brother”). 
 On the PCL-5, Kyle did not report any current PTSD symptoms, or any TRASC 
symptoms. Additionally, he reported not currently using substances and scored at a minimal risk 
of substance abuse with 2 out of 14 on the SSI-SA. He endorsed going for help, having had a 
problem with substance use in the past, and having a family member with problem substance 
use. He admitted that he sometimes misses “family get-togethers and stuff like that. I don’t 
attend them because the alcohol is there”.   
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 When Kyle’s substance use was at its worst, he reported experiencing avoidance about 
once per week, and used tobacco and alcohol daily or almost daily for most of the day. He said, 
“well when I was drinking heavy, I started thinking of things that weren’t very nice, people that 
bothered me at work, stressful feelings” and that he was bothered by these thoughts and feelings; 
however, he continued “drinking in the morning and drinking all day” regardless of the fact that 
alcohol caused him to experience these maladaptive patterns of thinking and feeling.  Figure 17 
details the PCR ratings obtained from Kyle. He reported that tobacco use did not cause his 
avoidance behaviours, nor did his avoidance behaviours cause his tobacco use. However, he 
reported that alcohol use caused him to have internal reminders about stressful events that he 
tried to avoid. In contrast, he reported that he never used alcohol to avoid these reminders. 
Figure 17: Summary of PCR Ratings for Kyle in Study 2 
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7.0 Study 2 Discussion 
 There were many benefits inherent in the current study that addressed limitations from 
the online study. For example, with the clinical sample, we were able to gain a more 
comprehensive clinical history and understand more about the sample than we were able to do 
with the Study 1 online participants. Moreover, due to the nature of recruitment, all of the 
individuals interviewed had been or were currently in treatment for substance abuse, in 
comparison to the smaller percentage of individuals with substance abuse recruited online. While 
there was a lower rate of potential diagnosis of SUD in the clinical sample versus those 
participating online due to the success of current treatments, there was a similar rate of PTSD. 
However, both studies share the same limitation of assessing only trauma-related symptoms and 
substance use classes, rather than behaviours. Nonetheless, the ability to ask further questions of 
the individuals interviewed for the clinical sample provided more information about the 
behaviours each individual was engaging in during their active substance use, such as fighting or 
increased sexual behaviours. 
 In fact, the ability to gain follow-up information from the clinical sample was useful for 
exploring the relationships between each individual’s perceptions of how their trauma symptoms 
and substance use related in a more in-depth manner. The current study was able to expand upon 
the online study in that more than a numerical rating of PCR was collected. The individuals in 
the current study were able to provide a detailed phenomenological account of the possible 
relationships between their trauma-related symptoms and SUD. Therefore, the inclusion of the 
clinical sample was useful in explaining how and why trauma symptoms related to substance use 
in addition to how much and in which direction, which was the extent to which Study 1 could 
provide details on the same perceived causal relationships.  
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 Overall, every individual in the clinical sample endorsed multiple lifetime and childhood 
traumatic experiences, with many reporting experiencing a traumatic event very early in life. 
This evidences the self-medication hypothesis, which posits that an individual experiences a 
traumatic event and then progresses to substance abuse in order to manage the effects of the 
trauma. Almost all participants endorsed experiencing at least one trauma-related symptom on 
the PCL-5, although only a quarter met the criteria for a probable diagnosis of current PTSD. 
During their collective worst times of substance abuse, all participants endorsed experiencing 
trauma-related reexperiencing and avoidance, suggesting that even if the individual did not 
currently meet the recommended cut-off score for a probable diagnosis of PTSD, it is entirely 
possible that they would have met the criteria during the periods where their substance use was at 
its worst. As well, all participants endorsed at least one item on the SSI-SA. However, the nature 
of the SSI-SA items revealed that even an individual not actively using substances could meet 
the “moderate to high risk” designation and require further assessment for an SUD. The majority 
of the participants scored at a minimal risk, again, even without actively using a substance.  
 The PCR results from the clinical sample study provide partial support for the self-
medication hypothesis (Brady, Back, & Coffey, 2004; Chilcoat & Breslau, 1998a; Khantzian, 
1985); trauma-related reexperiencing was perceived to be significantly causal of overall 
substance use. As a group, however, the participants did not perceive avoidance or dissociative 
experiences to be significantly causal of their overall substance use. Additionally, trauma-related 
symptoms were perceived to be significantly causal of tobacco use. Amphetamine use trended 
toward also being caused by trauma-related symptoms. No other substances were reported to be 
significantly caused by trauma-related symptoms. However, alcohol use, cocaine use, sedatives 
  
96 
use, and opioid use were all perceived to be caused by more so than a cause of trauma-related 
symptoms, although these relationships were not significant across participants.  
 In the current study, participants generally endorsed substance use as caused by trauma-
related symptoms, with one exception. Inhalants were perceived to be equally a cause and an 
effect of trauma-related symptoms. This does suggest that there is also evidence against the self-
medication hypothesis. Similarly, it also evidences Khantzian’s (1985, 1997) assertions that, 
given specific drug properties interact with a person’s inner psychological state, and specific 
drugs would may be used in a goal-directed manner for suppressing or enhancing particular 
states. Specifically, tobacco was perceived to be significantly more of an effect than a cause of 
trauma-related symptoms, and the majority of other substances had a similar but non-significant 
relationship with the trauma-related symptoms. However, as was suggested in Study 1, the use 
and reason for use of each substance varied significantly among the participants, and this should 
influence the interpretation of these group-level results.  
 Apart from the significant results and trends that were identified in the current study, 
certain general conclusions can be drawn. In the case of trauma-related symptoms, 
reexperiencing trauma, but not trauma-related avoidance and dissociation, was generally 
perceived to be causal of substance use. It can also be concluded that the relations between 
trauma-related symptoms and general or specific substance use were often perceived to be 
bidirectional and somewhat intercausal, such that although many substances were seen to be 
caused by trauma-related symptoms, individuals often clarified that they entered into cycles of 
substance use where there was intercausality between trauma-related symptoms and their 
substance use. These findings are generally indicative of the self-medication hypothesis, which is 
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consistent with most literature, as the self-medication hypothesis was a framework developed in 
clinical settings to explain substance abuse (Brady et al., 2004; Chilcoat & Breslau, 1998a).  
 There were limitations to the current study that were also inherent in the online study. 
Retrospection of when substance use was at its worst and then deriving causal connections from 
these time periods may be impaired by the substance abuse that was ongoing during these 
periods. Indeed, many participants expressed a high level of uncertainty regarding how they 
might most appropriately answer certain PCR questions, claiming their degree of intoxication 
prevents much insight into the causes and consequences of their behaviour. It is likely that, given 
the number and degree to which substance abuse was reported by the clinical sample, many 
individuals’ abilities to recall the causal situations between specific substances used and specific 
trauma-related symptoms was impaired by whichever substances they were currently taking, 
particularly in the case of dissociative experiences (e.g., derealization or depersonalization).   
 Additionally, it should be noted that many of the mean cause and effect PCR ratings 
between substance use and trauma-related symptoms are stronger in the clinical study than those 
from the online study. It is possible that this is due to differences in test-taking approaches when 
answering questions online as opposed to face to face. Further, in the online study, the order of 
the PCR items was such that the causal symptom being investigated stayed constant through all 
of the different symptoms investigated as an effect. For example, if reexperiencing was 
investigated as a cause, all of the substances would be presented for rating as an effect before 
another causal symptom, such as avoidance, would replace reexperiencing. Conversely, for the 
clinical sample, participants’ causal ratings were queried in what was felt to be a more fluid 
manner. For example, reexperiencing was investigated as a cause of alcohol use, and then 
immediately the reverse question was asked, specifically, alcohol use was investigated as a cause 
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of reexperiencing. This allowed for a more natural progression through the PCR questions, and 
may have impacted the stronger mean cause and effect ratings.  
 Considering the limitations present in the current study, we can conclude that the PCR 
ratings and personal experiences reported generally support the self-medication hypothesis to 
explain the comorbidity between substance use and trauma-related symptoms. Further research 
in the area of comorbidity should focus on situations in which sex difference and substance use 
behaviours and trauma-related symptoms causally relate. Additionally, a more sensitive measure 
of substance abuse, such as the WHO ASSIST measure (WHO ASSIST Working Group, 2002), 
should be used to determine active substance use and the presence of an SUD. 
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8.0 General Discussion 
 This thesis examined the perceived causal relations (PCR) between substance use, 
substance use disorders, and trauma-related symptoms in both an online convenience sample 
(Study 1) and a sample of individuals who had attended or were currently attending treatment for 
a substance use disorder (Study 2). The thesis results were consistent with the literature detailing 
the comorbidity between trauma and stressor-related disorders, such as PTSD and SUD. The 
results provided evidence of the frequency of comorbidity that was consistent with literature, as 
well as implicating the self-medication hypothesis partly as an explanation of comorbidity such 
that most individuals experiencing a traumatic or stressful experience indicated using substances 
in order to manage the psychological effects of the traumatic experience, in particular, trauma-
related reexperiencing and avoidance. In contrast, many participants, and particularly the 
treatment-seeking sample of Study 2, also acknowledged the capacity of their substance use to 
invoke dissociative experiences. These results suggest that clients who present with traumatic 
experiences, SUDS, PTSD or other trauma-related disorders, or any combination should be 
screened for comorbidity and dissociative tendencies (e.g. Carlson et al., 2012). 
 The present results tend to affirm the potential usefulness of the PCR methodology in 
parsing individual experiences in order to understand, diagnosis, and treat comorbid disorders. 
For treatment, the PCR methodology can be used to create case profiles for individuals 
presenting with multiple symptoms and comorbid disorders as was illustrated in the case 
descriptions compiled from participants in Study 2. PCR can aid clinicians in understanding the 
subjective and idiographic nature of various clients’ symptom presentations such as the 
perceived relations between symptoms, the temporal trajectory of the various symptoms or 
disorders, and the differences in which symptoms or disorders may need to be treated first. 
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Additionally, PCR scaling could be used at pre-treatment, during treatment, and post-treatment 
to examine the maintenance and relapse of each client. In fact, many of the clinical participants 
in Study 2 reported that although their trauma experiences may have preceded a diagnosis of 
PTSD or subsequent substance use, their trauma-related symptoms and substance use came to 
form a cycle in which both trauma-related symptoms and substance use became causal of the 
other. This suggests that the comorbidity between the two conditions can often be extremely 
complex and difficult to treat, especially in terms of whether the trauma symptoms or the 
substance use should be managed first, separately, or concurrently, and given the fact that 
treatment outcomes for this specific comorbidity are worse than other dually-diagnosed disorders 
(e.g. Greenfield, Back, Lawson, & Brady, 2010; Najavits & Hien, 2013; Ouimette, Ahrens, 
Moos, & Finney, 1998; Ouimette, Finney, & Moos, 1999). Research has also shown that 
individuals with substance use and comorbid anxiety disorders are more likely to perceive a need 
for professional intervention and actually seek help than those with substance use disorders and 
no comorbidity (Mojtabai, Olfson, & Mechanic, 2002) and those with anxiety or major 
depression and comorbid substance use disorders are also likely to perceive a need for help and 
seek out professional intervention (Grella, Karno, Warda, Moore, & Niv, 2009; Oleski, Mota, 
Cox, & Sareen, 2010). Given that PTSD was previously classified as an anxiety disorder (DSM-
IV-TR; APA, 2000), and many of the individuals in the clinical sample report diagnoses of 
anxiety and depression along with PTSD and SUD, it is possible that the individuals who entered 
into in-patient treatment did so due to this comorbidity and perceived need for help. 
8.1 Limitations and Future Directions 
 As previously detailed, there are multiple limitations that need to be considered when 
interpreting the results of this thesis. The SSI-SA and PTSD measures used for both studies are 
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self-report measures and likely diagnoses of either were based on recommended cut-off scores. 
These recommended scores do not provide a definitive diagnosis, but rather merely indicate the 
possible presence of these disorders. The measures used, especially the PCR, are retrospective 
and therefore are reliant on the individuals correctly remembering and interpreting past events, 
something that may be difficult when the defining characteristic of the individuals was general or 
clinically relevant substance abuse. As well, the measures were completed at a single time point 
and therefore lack the longitudinal evidence that would be useful to determine the causal 
relations between trauma-related symptoms and substance use over time. Additionally, while the 
inclusion of a clinical sample in Study 2 was meant to ameliorate the concerns from Study 1 
limitations, the sample was small and consisted mostly of men, precluding further analysis of sex 
differences.  
 Future studies with the PCR would benefit from longitudinal studies where the ratings are 
collected as baseline, during treatment, and post-treatment to follow how each individual 
changes across treatment and to track if certain symptom changes predict relapse. Similarly, 
while the substance classes were useful in determining how trauma symptoms related to a 
specific substance, it would also be useful to examine how trauma symptoms relate to substance 
use behaviours such as risk-taking, social isolation, or imprisonment. Lastly, it would be useful 
to assess other personal characteristics, especially if used in a clinical setting. For example, 
Khantzian (1985, 1997) has posited that personality traits may impact substance of choice along 
with inner psychological states. In a clinical setting, it would be useful to understand more about 
a client in order to design and implement a customized treatment based on their clinical 
presentation and the causal interrelationships between their symptoms. Additionally, it would be 
further beneficial to include items that discriminate between the number of traumas an individual 
  
102 
has experienced versus the number of exposures and severity of each of the traumas, to better aid 
in appraisal. Having other raters, such as family members, confirm the chronicity of these events 
would also be beneficial to aiding in appraisal, although this may be more difficult for family 
members to accurately assess if the individual is more prone to internalizing versus externalizing 
symptomatology. 
8.2 Conclusion 
 Psychological trauma, PTSD and related symptoms, as well as substance abuse are 
common presentations in many individuals and are unfortunately often difficult to treat. This 
thesis contributes to the literature concerning the comorbidity between PTSD and SUD by 
examining the causal interrelationships between trauma-related symptoms and substance use in 
both men and women in an online community sample and in men and women who are currently 
in or have been treated for SUDs. In general, it was found that comorbidity between t PTSD and 
SUD can be partially explained by the self-medication hypothesis in which individuals attempt to 
manage their trauma-related symptoms with substance abuse, which then creates an increasingly 
difficult addictive cycle. In particular, it was shown that trauma-related reexperiencing was 
perceived to be more so a cause than an effect of substance use, and that tobacco is a substance 
perceived to be more so caused by than a cause of trauma-related symptoms. The combined 
results from both the online sample and the clinical sample however underscore the complex 
bidirectional relationship often present between trauma exposure, trauma-related symptoms and 
substance abuse. The PCR methodology can be used to create a client-centered and idiographic 
approach to parsing this complexity and aid in the planning and maintenance of treatment for 
comorbid PTSD and SUD treatment, due to the ability to adapt the methodology to fit the unique 
presentation of each client. 
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10.0 Appendices 
Appendix A 
Life Events Checklist (LEC-5) 
Listed below are a number of difficult or stressful things that sometimes happen to people. Please 
indicate whether each event happened to you personally during the time period indicated with 
either YES or NO. 
1. Natural disaster (for example, flood, hurricane, tornado, earthquake) during anytime in 
your life. 
2. Fire or explosion  during anytime in your life. 
3. Transportation accident (for example, car accident, boat accident, train wreck, plane 
crash) during anytime in your life. 
4. Serious accident at work, home, or during recreational activity during anytime in your 
life. 
5. Exposure to toxic substances (for example, dangerous chemicals, radiation) during 
anytime in your life. 
6. Physical assault (for example, being attacked, hit, slapped, kicked, beaten up) during 
anytime in your life. 
7. Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, 
bomb) during anytime in your life. 
8. Sexual assault (rape, attempted rape, made to perform any type of sexual act through 
force or threat or harm) during anytime in your life. 
9. Other unwanted or uncomfortable sexual experience during anytime in your life. 
10. Combat or exposure to a war-zone (in the military or as a civilian) during anytime in your 
life. 
11. Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war) during 
anytime in your life. 
12. Life-threatening illness or injury during anytime in your life. 
13. Severe human suffering during anytime in your life. 
14. Witnessed sudden violent death (for example, homicide, suicide) during anytime in your 
life. 
15. Witnessed sudden accidental death during anytime in your life. 
16. Serious injury, harm, or death you caused to someone else during anytime in your life. 
17. Any other very stressful event or experience during anytime in your life. 
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Appendix B 
Adverse Childhood Experiences (ACE) 
 
While you were growing up, during your first 18 years of life: 
 
(Yes or no) 
 
1. Did a parent or other adult in the household often or very often… Swear at you, insult you, put 
you down, or humiliate you? OR Act in a way that made you afraid that you might be physically 
hurt? 
 
2. Did a parent or other adult in the household often or very often…Push, grab, slap, or throw 
something at you? OR Ever hit you so hard that you had marks or were injured? 
 
3. Did an adult or person at least 5 years older than you ever…Touch or fondle you or have you 
touch their body in a sexual way? OR Attempt or actually have oral, anal, or vaginal intercourse 
with you? 
 
4. Did you often or very often feel that …No one in your family loved you or thought you were 
important or special? OR Your family didn’t look out for each other, feel close to each other, or 
support each other? 
 
5. Did you often or very often feel that …You didn’t have enough to eat, had to wear dirty 
clothes, and had no one to protect you? OR Your parents were too drunk or high to take care of 
you or take you to the doctor if you needed it? 
 
6. Were your parents ever separated or divorced? 
 
7. Was your mother or stepmother: Often or very often pushed, grabbed, slapped, or had 
something thrown at her? OR Sometimes, often, or very often kicked, bitten, hit with a fist, or hit 
with something hard? OR Ever repeatedly hit at least a few minutes or threatened with a gun or 
knife? 
 
8. Did you live with anyone who was a problem drinker or alcoholic or who used street drugs? 
 
9. Was a household member depressed or mentally ill, or did a household member attempt 
suicide? 
 
10. Did a household member go to prison? 
 
Now add up your “Yes” answers: 
 
__________ 
 
This is your ACEs score 
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Appendix C 
Posttraumatic Checklist (PCL-5) & Trauma-related Altered States of Consciousness (TRASC) 
Below is a list of problems that people sometimes have in response to a very stressful 
experience. Please read each problem carefully and then circle one of the numbers to the right to 
indicate how much you have been bothered by that problem in the past month. 
0 = Not at all 
1 = A little bit 
2 = Moderately 
3 = Quite a bit 
4 = Extremely 
In the past month, how much were you bothered by: 
1. Repeated, disturbing, and unwanted memories of the stressful experience? 
 
2. Repeated, disturbing dreams of the stressful experience? 
 
3. Suddenly feeling or acting as if the stressful experience were actually happening again (as if 
you were actually back there reliving it)? 
 
4. Feeling very upset when something reminded you of the stressful experience? 
 
5. Having strong physical reactions when something reminded you of the stressful experience 
(for example, heart pounding, trouble breathing, sweating)? 
 
6. Avoiding internal reminders of the stressful experience (for example, thoughts, feelings, or 
physical sensations)? 
 
7. Avoiding external reminders of the stressful experience (for example, people, places, 
conversations, objects, activities, or situations)? 
 
8. Trouble remembering important parts of the stressful experience? 
 
9. Having strong negative beliefs about yourself, other people, or the world (for example, having 
thoughts such as: I am bad, there is something seriously wrong with me, no one can be 
trusted, the world is completely dangerous)? 
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10. Blaming yourself or someone else strongly for the stressful experience or what happened after 
it? 
 
11. Having strong negative feelings such as fear, horror, anger, guilt, or shame? 
 
12. Loss of interest in activities that you used to enjoy? 
 
13. Feeling distant or cut off from other people? 
 
14. Having trouble experiencing positive feelings (for example, being unable to have loving 
feelings for those close to you, or feeling emotionally numb)? 
 
15. Feeling irritable or angry or acting aggressively? 
 
16. Taking too many risks or doing things that cause you harm? 
 
17. Being “superalert” or watchful or on guard? 
 
18. Feeling jumpy or easily startled? 
 
19. Having difficulty concentrating? 
 
20. Trouble falling or staying asleep? 
 
21. Flashbacks of a Traumatic Event - Feeling as if a traumatic event from the past is happening in 
the present. Feeling like you are RELIVING the event, rather than only remembering it. 
 
22. Altered Sense of Time - Having little sense of the passage of time, or feeling like time has 
slowed down, speeded up, or seems like it is stopped or standing still. 
 
23. Marked Loss of Emotional Feeling - Feeling completely numb, hollow, and lifeless inside, as 
if you are already dead. 
 
24. Feeling like What You are Experiencing is Not Real - A change in the way you perceive or 
experience the world or other people, so that things seem dreamlike, strange or unreal. 
 
25. Out of Body Experience - Feeling detached or separated from your body, for example, feeling 
like you are looking down on yourself from above, or like you are an outside observer of your 
own body. 
 
26. Feeling like a Part of Your Body is Not Your Own - For example, like your hands or feet are 
strange, unfamiliar, disconnected, not there, or that they do not belong to you. 
 
27. Identity Confusion - Having an extremely unstable sense of self; feeling like you don't know 
who you are. 
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28. Divided or Multiple Senses of Self - Feeling like your sense of self is divided into different 
parts, that who you are seems to change across time, or feeling like you are made up of two or 
more different people. 
 
29. Losing time for periods of at least 10 minutes, so that you have very little (if any) awareness 
or memory for what happened during the missing periods of time. 
 
30. Hearing voices inside your head that seem different from your own voice, and different from 
your own thoughts. 
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Appendix D 
Simple Screening Instrument for Substance Abuse (SSI-SA) 
Simple Screening Instrument for Substance Abuse Self-Administered Form 
Directions: The questions that follow are about your use of alcohol and other drugs. Your 
answers will be kept private. Mark the response that best fits for you. Answer the questions in 
terms of your experiences in the past month. 
 
During the last month...                      YES     NO 
1. Have you used alcohol or other drugs? (Such as wine, beer, hard liquor, 
pot, coke, heroin or other opioids, uppers, downers, hallucinogens, or 
inhalants) 
  
2. Have you felt that you use too much alcohol or other drugs?   
3. Have you tried to cut down or quit drinking or using alcohol or other 
drugs? 
  
4. Have you gone to anyone for help because of your drinking or drug use? 
(Such as Alcoholics Anonymous, Narcotics Anonymous, Cocaine 
Anonymous, counselors, or a treatment program.) 
  
5. Have you had any health problems? For example, have you: 
            ___Had blackouts or other periods of memory loss? 
            ___Injured your head after drinking or using drugs? 
            ___Had convulsions, delirium tremens (“DTs”)? 
            ___Had hepatitis or other liver problems? 
            ___Felt sick, shaky, or depressed when you stopped? 
            ___Felt “coke bugs” or a crawling feeling under the skin after you stopped using drugs? 
            ___Been injured after drinking or using? 
            ___Used needles to shoot drugs? 
 6.   Has drinking or other drug use caused problems between you and 
       your family or friends? 
   
7.  Has your drinking or other drug use caused problems at school or at 
      work? 
  
8.  Have you been arrested or had other legal problems? (Such as 
      bouncing bad checks, driving while intoxicated, theft, or drug 
      possession.) 
  
9.  Have you lost your temper or gotten into arguments or fights while 
      drinking or using other drugs? 
  
10.  Are you needing to drink or use drugs more and more to get the effect 
        you want? 
  
11.  Do you spend a lot of time thinking about or trying to get alcohol or 
        other drugs? 
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12.  When drinking or using drugs, are you more likely to do something 
        you wouldn’t normally do, such as break rules, break the law, sell 
        things that are important to you, or have unprotected sex with 
        someone? 
  
13. Do you feel bad or guilty about your drinking or drug use? 
 
  
 
The next questions are about your lifetime experiences.       YES       NO 
14. Have you ever had a drinking or other drug problem?   
15. Have any of your family members ever had a drinking or drug 
       problem? 
  
16. Do you feel that you have a drinking or drug problem now?   
 
Thanks for filling out this questionnaire. 
 
Scoring for the Simple Screening Instrument for Substance Abuse 
Name/ID No.: ______________________________          Date: _____________________ 
Place/Location: 
__________________________________________________________________________ 
Items 1 and 15 are not scored. The following items are scored as 1 (yes) or 0 (no): 
___ 2     ___ 7      ___ 12 
___ 3     ___ 8      ___ 13 
___ 4     ___ 9      ___ 14 
___ 5 (any items listed) ___ 10     ___ 16 
___ 6    ___ 11 
Total score: ____       Score range: 0-14 
Preliminary interpretation of responses: 
Score  Degree of Risk for Substance Abuse 
0-1   None to low 
2-3   Minimal 
>4   Moderate to high: possible need for further assessment 
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Appendix E 
PCR Items For Study 1 
In the past month, how much were you bothered by: 
 
Answer Key: 
Not at all in the past month 
Once in the past month 
Two or three times in the past month 
About once per week in the past month 
About once daily or almost daily 
Multiple times daily or almost daily 
Daily or almost daily for most of the day 
Skip this question 
 
1. Repeated, Disturbing, and Unwanted Memories of a Stressful Experience: Repeated, 
disturbing, and unwanted memories of a stressful experience 
 
2. Feeling Very Upset When Something Reminded You of a Stressful Experience: Feeling 
very upset when something reminded you of a stressful experience. 
 
3. Avoiding Internal Reminders of a Stressful Experience: (For example, thoughts, feelings, 
or physical reactions). 
 
4. Avoiding External Reminders of a Stressful Experience: (For example, people, places, 
conversations, objects, activities, or situations). 
 
5. Flashbacks of a Traumatic Event: Feeling as if a traumatic event from the past is 
happening in the present. Feeling like you are RELIVING the event, rather than only 
remembering it. 
 
6. Marked Loss of Emotional Feeling: Feeling completely numb, hollow, and lifeless inside, 
as if you are already dead. 
 
7. Feeling like What You are Experiencing is Not Real: A change in the way you perceive 
or experience the world or other people, so that things seem dreamlike, strange or unreal. 
 
8. Out of Body Experience: Feeling detached or separated from your body, for example, 
feeling like you are looking down on yourself from above, or like you are an outside 
observer of your own body. 
 
9. Feeling like a Part of Your Body is Not Your Own: For example, like your hands or feet 
are strange, unfamiliar, disconnected, not there, or that they do not belong to you. 
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10. Hearing Voices Inside your Head: (That seem different from your own voice, and 
different from your own thoughts). 
 
11. Anxiety: Feeling nervous, anxious, or on edge. 
 
12. Worrying: Not being able to stop or control worrying. 
 
13. Depression: Feeling down, depressed, or hopeless. 
 
14. Lack of Interest or Pleasure: Little interest or pleasure in doing things. 
 
15. Use of Tobacco Products: (Cigarettes, Chewing Tobacco, Cigars, etc.). 
 
16. Use of Alcoholic Beverages: (Beer, Wine, Spirits, etc.). 
 
17. Use of Cannabis: (Marijuana, Pot, Grass, Hash, etc.). 
 
18. Use of Cocaine and related drugs: (Coke, Crack, etc.). 
 
19. Use of Amphetamine Type Stimulants: (Speed, Diet pills, Ecstasy, etc.). 
 
20. Use of Inhalants: (Nitrous, Glue, Petrol, Paint thinner, etc.). 
 
21. Use of Sedatives or Sleeping Pills: (Valium, Serepax, Rohypnol, etc.). 
 
22. Use of Hallucinogens: (LSD, Acid, Mushrooms, PCP, Special K, etc.). 
 
23. Use of Opioids: (Heroin, Morphine, Methadone, Codeine, etc.). 
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Appendix F 
PCR Items for Study 2 
How frequently did you experience this problem when your substance use was at its worst? 
Not at all in your history/experiences (0) 
Once in your history/experiences (1) 
Two or Three times in your history/experiences (2) 
About Once per Week in your history/experiences (3) 
About Daily or Almost Daily (4) 
Multiple Times Daily or Almost Daily (5) 
Daily or Almost Daily for Most of the Day (6) 
Skip this Question 
 
_____  1. Repeated, disturbing, and unwanted memories of a stressful experience AND/OR 
 feeling very upset when something reminded you of a stressful experience. 
 
_____  2. Avoiding internal reminders of the stressful experience (for example, thoughts, 
 feelings, or physical reactions) AND/OR avoiding external reminders of the stressful 
 experience (for example, people, places, conversations, objects, activities, or situations). 
 
_____  3. A change in the way you perceive or experience the world or other people, so that 
 things seem dreamlike, strange or unreal AND/OR feeling detached or separated from 
 your body, for example, feeling like you are looking down on yourself from above, or 
 like you are an outside observer of your own body. 
 
_____ 4. Use of Tobacco Products (Cigarettes, Chewing Tobacco, Cigars, etc.). 
 
_____ 5. Use of Alcoholic Beverages (Beer, Wine, Spirits, etc.). 
 
_____ 6. Use of Cannabis (Marijuana, Pot, Grass, Hash, etc.). 
 
_____ 7. Use of Cocaine and related drugs (Coke, Crack, etc.). 
 
_____ 8. Use of Amphetamine Type Stimulants (Speed, Diet pills, Ecstasy, etc.). 
 
_____ 9. Use of Inhalants (Nitrous, Glue, Petrol, Paint thinner, etc.). 
 
_____ 10. Use of Sedatives or Sleeping Pills (Valium, Serepax, Rohypnol, etc.). 
 
_____ 11. Use of Hallucinogens (LSD, Acid, Mushrooms, PCP, Special K, etc.). 
 
_____ 12. Use of Opioids (Heroin, Morphine, Methadone, Codeine, etc.). 
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 Reexperiencing 
Reminders 
Avoidance Dissociation 
(Depersonalization & 
Derealization) 
Tobacco Products 
(Cigarettes, chewing 
tobacco, cigars, etc.) 
cause    
effect    
Alcoholic Beverages (beer, 
wine, spirits) 
cause    
effect    
Cannabis (marijuana, pot, 
grass, hash, etc.) 
cause    
effect    
Cocaine & related drugs 
(coke, crack, etc.) 
cause    
effect    
Amphetamine-type 
Stimulants (Speed, diet 
pills, ecstasy, etc.) 
cause    
effect    
Inhalants (Nitrous, glue, 
petrol, paint thinner, etc.) 
cause    
effect    
Sedatives or Sleeping Pills 
(Valium, Serepax, 
Rohypnol, etc.) 
cause    
effect    
Hallucinogens (LSD, acid, 
mushrooms, PCP, Special 
K, etc.) 
cause    
effect    
Opioids (heroin, morphine, 
methadone, codeine, etc.) 
cause    
effect    
Cause = how much the substance use is seen as a cause of another symptom 
Effect = how much the substance use is seen as the effect of another symptom 
Rating Scale: 
0 – Not at all 
5 – Moderate cause 
10 – Strong cause 
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